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Abstract of thesis entitled: 
Transient cell cycle arrest and autophagy induction in colorectal cancer HT29 
cell line by sodium 5,6-benzylidene-L-ascorbate 
Colorectal cancer is the second most common form of malignancy in Hong 
Kong. Conventional synthetic chemotherapeutic drug, 5-FU, shows effective 
anti-tumor properties against colorectal cancer, however, the destructive effect of 
5-FU on central nervous systems has recently been found. Because of the alarming 
risk of colorectal cancer and the severe side effects associated with the conventional 
chemotherapy, both pharmaceutical and clinical laboratories around the world are 
continuously searching for novel and effective anticancer compounds from natural 
sources as alternative chemotherapeutic agents . 
Sodium 5,6-benzylidene-L-ascorbate (SBA), a benzaldehyde derivative of 
sodium ascorbate isolated from the figs, has been demonstrated its anti-tumor 
properties by tumor reduction in clinical studies, but the underlying mechanisms 
mediating its cytotoxicity remain unclear. In an effort to evaluate the molecular 
mechanisms of SBA with reference to sodium ascorbate (SAA), short term 
treatments of SAA and SBA at the pharmacological doses (0.3 -20mM ) in 
synchronized human colorectal cancer HT29 cells were employed in current study. 
SAA induced catalase-inhibitable oxidative stress with the induction of transient cell 
cycle arrest and rupture of lysosomes, whereas SBA triggered rapid and remarkable 
oxidative stress, altered the expression of cyclins and their associated regulatory 
proteins, and resulted in transient cell cycle- independent growth arrest. This arrest 
was inhibited completely by pre-incubation with an oxidant scavenger, 
N-acetylcysteine (NAC), but not by other oxidation inhibitors such as 
i 
diphenyleneiodonium chloride (DPI), rotenone, A^oj-Nitro-L-arginine methyl ester 
hydrochloride (L-NAME) although they partially reduced the production of reactive 
oxygen species (ROS). In addition, SBA induced autophagy with the formation of 
acidic autophagic vacuoles and the dramatic activation of survival kinase AKT. 
Taken all evidence together, the transient cell cycle -independent arrest and 
autophagy in SBA treatment are likely associated with the participation of 
NAC-inhibitable oxidative stress. 
ii 
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Chapter 1 General Introduction 
1.1. Colon cancer 
1.1.1. Colon cancer statistic in Hong Kong 
Colon cancer, also known as colorectal cancer or large bowel cancer, includes 
cancerous growth in the colon and the rectum. According to the statistics in the 
Hong Kong Cancer Registry 2007, colorectal cancer is the second leading cause of 
cancer mortality in Hong Kong, killing a total of 1538 in 2004 (HK Cancer Statistics 
2004). The alarming risk of colorectal cancer does not restrict to Hong Kong as the 
incidence rate of colorectal cancer ranks third around the world (Jemal et al, 2004) 
that warrants special global attention to the understanding of the risk factors, 
prevention strategies and drug developments for colorectal therapy. Colorectal 
cancer is commonly developed at the age above 50; it is more common in male than 
female (male: female = 1.3 : 1) while the mortality in both sexes is more or less the 
same (HK Cancer Statistics 2004, http://www3.ha.org.hk/cancereg/eng/canstat2004. 
m-
1.1.2. Development of colon cancer 
Colon cancer development involves series of pathological transformation of 
normal colon epithelium to adenomatous polyps and finally to an invasive cancer 
with the alternation in tumor suppressor genes and oncogenes (Takami et al., 1995). 
At the later stage of carcinoma, mutation of tumor suppressor genes is found in more 
than 80% of colorectal cancers (Hardy et al., 2000). Lifestyle factors such as diet 
habits, physical activities and alcohol consumption are still controversial for the 
development of the colon cancer (Moskal et al., 2006; Park et al., 2005; Samad et al., 
2004), while hereditary or familial background which developed by the germ cells 
mutation in one of DNA mismatch repair (MMR) gene and Adenomatous Polyposis 
Coil (APC) gene has been confirmed in 5-10% of total reported cases (Narayan et al., 
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2003; Benito et al.，2006). Apart from the genetic mutation, long-standing 
inflammation increases the risk of cancer development, especially in the colon 
whose anti-oxidative capacity is rather low in comparison with the rest of the 
gastrointestinal tract (Cable et al , 1992; Hardy et a l , 2000; Xie & Itzkowitz’ 2008). 
1.1.3. Treatment 
Surgical resection and radiotherapy along with adjuvant chemotherapy are the 
current strategies for cancer treatment. Chemotherapy is generally for controlling the 
spread of the tumor and preventing the recurrence of any unkilled cancer cells that 
remain after surgery in patients with tumor in Dukes' stage III (Dukes CE, 1932) in 
which the cancer is metastasized to the lymph nodes or extra-regional sites 
(Macdonald et al.,1999). In 2004, percentage of Hong Kong colon cancer patients 
belonging to stage III accounts for around 30% of the total reported cases; effective 
chemotherapy is therefore urged for patients with malignant cancers. Cancer cells 
are groups of cells which can evade from the recognition of host immune system and 
most of them lack of suppressors (e.g., p53 and p21) to turn on self-suicide process 
under blockage of cell division. 5-Fluorouracil (5-FU), a thymidylate synthase 
inhibitor, is commonly used to treat colon cancer for decades by incorporating itself 
into the genome of cancer cells, and thus blocking cancer cells from division (Yau et 
a l , 2006). Levamisole, an adjuvant for host immunity (Abdalla et al., 1995), or 
Leucoroin, a folinic acid assists 5-FU in binding to thymidylate synthase, increases 
the effectiveness of cancer killing (Scheithauer et al., 1998). Besides side effects like 
nausea, vomiting, diarrhea, and hair loss, recent research on 5-FU has also reported 
to destruct myelin sheath of the central nervous system (Shehata et al., 2003). Since 
no conventional therapy provides satisfactory cure for colon cancer, natural products 
with anti-cancer activity but no major side effects may provide an alternative 
therapeutic regiment. As mentioned above, anti-oxidant capacity of colon is lower 
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than the rest of the gastrointestinal sectors (Blau et al.，1999); this property of the 
colon cancer cells provides a new direction for the development of an anti-cancer 
drug which kills cancer cells by induction of oxidants. 
1.2. Sodium L-ascorbate (SAA) and Sodium 5,6-benaylidene-L- ascorbate 
(SBA) 
Ph 
H O O H 0 人 0 
Na〇 O H NaO OH 
Sodium L-ascorbate (SAA) Sodium ,6-benzylidene-L-ascorbate (SBA) 
1.2.1 Sodium L-ascorbate (SAA) 
Sodium ascorbate (SAA), a non-acidic form of vitamin C, was discovered by 
Dr. Albert Szent-Gyorgyi who was awarded the Nobel Prize in Physiology or 
Medicine in 1937. SAA is essential in scavenging oxidants in the cells and 
biological fluid, and it also acts as cofactors of some enzymes in many biochemical 
reactions (Thomas et al., 2005). The antioxidative capacity of SAA is due to the high 
reduction potential from its carbon-carbon double bond which readily donates one or 
two hydrogen atoms and electrons to the oxidants and water (May, 1998). Besides 
its antioxidative capacity, SAA is important to cure scurvy and prolong survival; 
therefore a daily consumption of 45 mg SAA is recommended by the World Health 
Organization to keep body healthy (WHO, 2004). SAA can also serve as oxidant by 
releasing ascorbyl radicals and H2O2 which can be detoxified by catalase. Emerging 
research suggested that oral intake or intravenous (i.v.) administration of SAA can 
probably arrest or kill cancer cells by apoptosis (Thomas et al., 2005). However, the 
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effectiveness of SAA is controversial because SAA is reported to promote 
carcinogenesis by removing mitochondrial superoxide anions in colon cancers with 
classical anti-tumor drug treatments (e.g., camptothecin or flavones) (Wenzel et al.， 
2004)，or to enhance chemical-induced mutations in skin cancer (D'Agostini et al., 
2005). Therefore, more extensive studies are needed to avoid undesirable opposite 
outcome before SAA is applied for chemotherapy. 
1.2.2. Sodium 5,6-benzylidene-L-ascorbate (SBA) 
Benzaldehyde is an anti-tumor agent isolated from the volatile fraction of the 
figs, and various derivatives of benzaldehyde such as [3-cyclodextrin benzaldehyde 
inclusion compound (CDBA), 4,6-benzildene-a-D-glucose (BG) and sodium 
5,6-benzylidene-L-ascorbate (SBA) have shown anti-tumor properties against 
Ehrlich carcinoma, adenocarcinoma 755 and colon 38 in mice (Rekha et al., 1994; 
Tatsumura et al., 1990). Among these benzaldehydes, SBA showed the most 
outstanding anti-tumor action by reducing the size of an inoperable human lung 
carcinoma to only 2.7% of its initial volume with 71 days of SBA intravenous 
administration (2 g twice a day), and a hepatocellular carcinoma in the 
3 ‘ -methyl-4-dimethylamino- azobenzene (DAB)-induced rat, especially without any 
prominent induction of side effects such as hair loss and body weight reduction. In 
addition, SBA also induced an in vitro cell death in leukemia cell lines, including 
ML-1, HL60, THP-1 and U-937, and salivary gland tumor cell line HSG (Sakagami 
et al., 1991 & 1999). Stability of SBA using high-performance liquid 
chromatography (HPLC) showed that SBA is composed of two disatereomers (S 
configuration and R configuration) which is rather stable in neutral pH without 
liberating ascorbic acid and benzaldehyde from cleavage (Sakagami et al., 1995). 
When SBA is dissolved in the culture medium with 10% fetal bovine serum at 37�C， 
the degradation rate is 38.1^g/ml/h (Sakagami et al , 1995) and only 1.3% of SBA is 
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degraded when lOmM of SBA was used during 2 hr treatment. 
Intravenous administration of SBA was unable to induce IL-2, tumor necrosis 
factor (TNF) or to activate polymorphonuclear cells (PMN) (Sakagami et al , 1991), 
implicating that the anti-tumor activity of SBA was due to its released ascorbyl 
radicals rather than an activation of the host immune system (Sakagami et al , 1998). 
Furthermore, 0.04% SBA was found in the SBA-treated leukemia, suggesting an 
inhibition of cancer cells and/or induction of cell death by SBA via the release of 
free radicals rather than incorporating itself into the cellular compartment (Sakagami 
et al , 1995). 
1.3. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) and 
their biological consequences 
Reactive oxygen species (ROS) are highly reactive free radicals or molecules 
which contain one or more uncoupled electrons in their highest atomic or molecular 
orbital (Boonstra & Post, 2004). Superoxide anion (02*-), hydrogen peroxide 
(H2O2), hydroxyl radical (•OH), singlet oxygen, peroxyl radicals (ROO.)，and 
hypochlorous acid (HOCl) are collectively called as ROS (Genestra, 2007; Valko et 
al, 2007) which are produced by cellular enzymes, e.g., nicotine adenine 
dinucleotide phosphate (NADPH) oxidase, xanthine oxidase, peroxisome and 
mitochondria (Valko et al., 2007). Among these oxygen species, hydroxyl radical is 
very dangerous because of its high reactivity and a very short half-life (Pastor et al., 
2000). 
Reactive nitrogen species (RNS), another group of cellular reactive molecules, 
has been shown its direct role in cellular signaling for vasodilatation and immune 
responses. Among the various members of the RNS family including nitric oxide 
(NO*), peroxynitrite anion (ONOO"), nitrate (NO^'), nitrite (NO^") and 3-nitotyrosine, 
N O (the reaction product of nitrogen oxide synthase, NOS) attract much attention 
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as they are important biological messengers for blood pressure regulation and 
smooth muscle relaxation (Takahashi, 2003). When N O reacts with superoxide 
during an inflammation, a more reactive peroxynitrite anion (ONOO") is produced in 
the immune system. 
ROS is not only a by-product of an aerobic respiration, but also acts as a 
secondary messenger in redox sensitive signaling cascades with the involvement of 
protein kinases/ phosphatases (e.g., tyrosine phosphatase/ kinase, MAPK and PKC) 
for cell proliferation and differentiation (Genestra, 2007). In order to ensure the 
accuracy of cellular signal transduction, redox homeostasis is maintained by both 
ROS generating systems and antioxidant defense systems. The antioxidant defense 
systems are composed of enzymatic (e.g., catalase, glutathions peroxidases, and 
superoxide dismutase) and non-enzymatic systems (e.g. vitamin K and P-carotene); 
they either inhibit the activation of ROS generating systems or neutralize the free 
radicals already formed (Genestra, 2007; Valko et al.，2007). When there is an 
increase in the reduction potential or a large decrease in the reducing capacity of the 
cellular redox couples, oxidative stress is resulted. Enormous studies reported that 
oxidative stress induces damages in the protein, lipid and DNA that lead to cell cycle 
arrest, apoptosis or even necrosis; that ultimately results in pathogenesis of 
cardiovascular and neurodegenerative diseases (Elahi et al., 2007; Loh et al., 2006). 
There are many pharmacological inhibitors for various oxidases, for examples, 
diphenyleneiodonium chloride (DPI) is a potent and reversible inhibitor of nitric 
oxide synthase and NADPH oxidase (Li et al., 1998); rotenone inhibits the electron 
transport in the complex I of mitochondria (Chen et al., 2003); oxypurinol is an 
allopurinol metabolite of xanthine oxidase inhibitor (Adis International Ltd., 2004; 
Landmesser et al., 2007); A^w-Nitro-L-arginine methyl ester hydrochloride (L-NAME) 
is an analog of arginine that inhibits NO production from NOS (Washo-Stultz et al., 
1999); N-acetylcysteine (NAC) is a superoxide scavenger (Schneider et a l , 2005); 
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and superoxide dismutase (SOD) converts O^— to H2O2 which is further converted 
to H2O by catalase (CAT) (Brioukhanov et al., 2004; Ray et al.，2002). These 
inhibitors are commonly used for studies of oxidative stress after drug treatment. 
1.4. Cell cycle 
A cell cycle is a series of events which are mainly divided into two parts 
(interphase and mitosis) leading to the division of one cell to two daughter cells. 
Sub-divisions of interphase include Gap 1 (Gl), S and Gap 2 (G2) which are 
regulated by different subsets of cyclins and cyclin-dependent kinases (Cdks). Cdks 
are serine/ threonine protein kinases which are in stable and inactive status until they 
are bound by corresponding cyclins for complete activities; while cyclins are 
regulators of the Cdks which periodically turnover during the cell cycle. When the 
complexes of cyclins/ Cdks are formed, they phophorylate multiple proteins for 
DNA replication and mitosis (Bowen et a l , 1998). The cyclins and Cdks involved in 
various phases are listed in the following Table 4.1: 
Table 4.1. Cyclins and cyclin dependent kinases involved in the cell cycle progression 
Complex Phase Function 
cyclin D/ Cdk 4,6 Gl Progression through the Gl phase 
cyclin E/ Cdk 2 Gl/ S Progression through the late Gl phase to the S phase 
cyclin A/ Cdk 2 S DNA synthesis 
cyclin A, B/ cdc 2 G2/ M Progression through the G2 phase and the M phase 
Table adopted from Bonnstra & Post, 2004. 
In order to ensure the genomic integrity, checkpoints between Gl/S and G2/M 
transition of the cell cycle are tightly regulated. At these checkpoints, the 
progression of cell cycle can be arrested for repairing damaged DNA caused by 
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irradiation or chemicals (Boonstra & Post, 2004). 
The G1 phase is a period in the cell cycle after the birth of a new cell to the 
beginning of the S phase; it is governed by 2 groups of cyclin/Cdk complexes, 
namely the cyclin D/ Cdk4，6，and the cyclin E/ Cdk2, respectively. The S phase is a 
period of genome replication which is governed by the cyclin A/ Cdk 2 complex; 
and the G2 phase is a period for preparation of cell division at the Mitosis (M) phase 
which is regulated by the cyclin B/ cdc2 complex (Muttry & Kirschner，1991). 
Throughout the cell cycle progression, the protein levels of cyclins oscillate for 
controlling Cdks activities. In response to stress such as DNA damage, starvation 
and/or oxidative stress, the cell is arrested at Gl , S or G2 phase with the 
up-regulation of certain Cdk-inhibitors (Ckl). Among different CKIs (e.g., p21, p27 
and p57), p2lWAFi/ciPi p|^yg ^ major role in cell cycle regulation by inhibiting the 
activity of cyclin/Cdk complexes (cyclin D/Cdk2,4; cyclin A, E/Cdk 2; cyclin B/cdc 
2) (Thomas et al.，2005). It has been shown that exposure of oxidative stress or DNA 
damage agents (e.g., doxorubicin and y-irradiation) up-regulated p21 expression that 
results in cell cycle arrest in Gl , S or G2 phase (Boonstra & Post，2004). Emerging 
evidence showed that manipulation of p21 expression for treating cancer via cell 
growth inhibition and/or cell death induction by chemotherapeutic drugs is a 
promising strategy to combat cancer (Waldman et al., 1995). 
1.5. Autophagy 
Autophagy is a highly conserved stress-response mechanism from yeast to 
mammalian cells for the proper growth, development and regulation of longevity by 
removal of damaged proteins or organelles, and turnover of intracellular components, 
e.g., essential amino acids. Three different types of autophagy, e.g. macroautophagy, 
microphagy and chaperone-mediated autophagy are already identified which 
basically differ from the transportation mechanisms of damaged substances to the 
8 
lysosomes where enzymatic digestion takes place (Ferraro & Cecconi，2007; 
Ogier-Denis & Codogno, 2003; Yorimitsu & Klinosky，2005). Depending on the 
duration and strength of the stress, and the different induction of the signal 
transduction pathways, autophagy plays both pro-survival and pro-suicidal roles 
during nutrient or growth-factor starvation, bacterial invasion, and oxidation 
(Ferraro & Cecconi，2007). With the advances in gene cloning and transfection, a 
battery of molecules including autophagy-related (ATG) genes, mTOR and 
PI3K/AKT proteins are identified in the regulation of autophagy (Ferraro & Cecconi, 
2007). Moreover, the development of confocal laser scanning microscopy and flow 
cytometry provides useful means for the study of autophagy. Morphologically, 
autophagy is characterized by the formation of autophagic acidic vesicles 
(autophagosomes) which is governed by a set of ATG genes (Ferraro & Cecconi, 
2007). Autophagosome was firstly formed with the sequestration of cytoplasmic 
materials by a double membrane vacuole, and then fuses with lysosome(s) to form a 
single membrane-surrounded vesicle where its content is digested by lysosomal 
hydrolase (Ogier-Denis & Codogno, 2003). Without the participation of an intact 
lysosome which is destablized by H2O2 or agents that increase the permeability of 
H+，the autophagosome-lysosome fusion is impaired (Luzio et al., 2007; Wan et al., 
2001). 
1.6 . Human colon cancer HT-29 cell line for anti-tumor study 
The increasing incidence of colorectal cancer urges our need for an effective 
treatment. Although the synthetic therapeutic drug, e.g., 5-FU, has shown its 
promising values in colon cancer treatment, its destructive side-effects on central 
nervous system (Shehata et a l , 2003) prompts us to seek for safer alternative 
chemotherapeutic agents, including natural products. SBA, a derivative of 
benzaldehyde isolated from figs, has been shown for its therapeutic value in treating 
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human liver inoperable carcinoma and rat hepatocarcinoma without observable 
side-effects (Sakagami et al , 1991，1999)，but its underlying mechanisms remain 
unclear. In this study, an in vitro study using the colon adenocarcinoma HT29 cell 
line, isolated from a Caucasian female patient, was used to investigate if SBA 
exhibited similar anti-tumor properties on colon cancer cells. The HT29 cell is 
extensively studied for the development of therapeutic drug because it is a good 
model for cell cycle progression and autophagy study (Petiot et al , 2000). Various 
methods were utilized to explore the in vitro cytotoxicity, cell cycle inhibition ability 
and induction of autophagy of SBA, while SAA was introduced as a reference for a 
comparison of their cytotoxicity with SBA. 
1.7. Aim of study 
The objectives of my study are: 
1. To evaluate and compare the cytotoxicity of SBA and SAA in short term 
treatment in order to mimic clinical i.v. regimens. 
2. To compare the source(s) of oxidative stress induced by SBA and SAA 
treatments. 
3. To find out the ROS-induced signaling mechanisms in autophagy induction 
and growth arrest. 
4. To ascertain the relationship between ROS, autophagy and growth arrest. 
1 0 
Chapter 2 Comparative studies of cytotoxicity of SAA and SBA in short term 
treatment 
2.1. Introduction 
According to the Mortality trend report of the Census and Statistics Department, 
neoplasm is the dominant cause of death in 2006, accounting for 32.9% of total 
death in Hong Kong (http://www.censtatd.gov.hk/home/index tc.isp). Among the 
neoplasms, the incident rate of colon cancer is increasing and it ranks third among 
different types of cancer. In spite of the promising therapeutic values of conventional 
synthetic drugs, e.g., 5-FU, the destructive side effects urge us to find out some 
alternative medicines from natural products with low side effects (Shehata et al, 
2003). Many natural products with potent in vitro anti-tumor activities, e.g., 
quercetin (Ranelletti et al., 2000), betulinic acid (Eiznhamer & Xu, 2004) have been 
proposed for cancer treatment. 
SBA, a benzyaldehyde derivative of ascorbate isolated from figs, has also shown 
anti-tumor activities against human inoperable lung carcinoma, adenocarcinoma 755 
and colon 38 in mice (Rekha et al, 1994; Tatsumura et al., 1990) without raising 
observable side-effects (Sakagami et al., 1998). Apart from strong induction of 
reactive oxygen species (ROS) production, there is little information on the 
anti-tumor mechanisms induced by SBA. SAA is an essential oxidant scavenger in 
the cells and biological fluid, as well as a cofactor of some enzymes in many 
biochemical reactions (Thomas et al, 2005). At pharmacological doses (0.3 - 20 
mM), SAA kill prostate cancer cells (Maramag et al., 1997), lymphoma cells and 
breast cancer cells (Chen et al., 2005) by releasing H2O2 that resulted in DNA 
damage (Maramag et al., 1997)，transient growth arrest (Thomas et al., 2005) and 
subsequent cell death (Maramag et al., 1997). Previous studies have shown that both 
SBA and SAA share some common properties, e.g., production of oxidants, methane 
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oxidation, and induction of apoptosis, but they responded differently to oxidant 
inhibitor, e.g., catalase (Sakagami et al., 1997); tempting a direct comparative 
cytotoxicities and their underlying mechanisms in the present study. 
The in vivo pharmacokinetics studies showed that SAA possesses anti-tumor 
effects at pharmacological doses (0.3-20 mM) (Chen et al., 2005), and the retention 
time was only 3 hours (hr) in the human body (Padayatty et al , 2004). In order to 
compare if equimolar SBA possesses similar therapeutic values, the dosage of both 
ascorbates used in the present study were restricted at 1.25 - 20 mM, and the 
treatment time was also limited to their possible retention time in the body, i.e., not 
more than 2 hr. To investigate the cytotoxic effects of these two ascorbates on HT29 
cells，clonogenic assay, MTT assay, trypan blue exclusion assay, and acridine orange 
staining were performed. Furthermore, a comparative cell specific cytotoxicity was 
also performed between colon cancer HT29 cells with normal human fibroblasts. 
The soft agar clonogenic assay is a time-consuming method for cell survival 
and proliferation measurement that can be used for both anchorage-dependent and 
-independent cells (Grenman et al., 1989). The MTT assay provides a quick access 
to determine the cell viability and proliferation after drug treatment, particularly 
suitable for massive samples analysis; it reflects the metabolic activity of the cells to 
convert the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide by 
succinate tetrazolium reductase into insoluble dark blue formazan crystal which can 
be solublized with dimethyl sulfoxide (DMSO) or ethanol for quantification 
(Mosmann, 1983). However, evaluation of the cytotoxicity by the MTT assay is 
hindered by false positive signal generated by the test compounds with strong 
reducing properties (e.g., sodium ascorbate). Trypan blue exclusion assay is another 
reliable assay for the measurement of viable cells whose intact cell membranes 
exclude trypan blue, a diazo dye. Dead cells are permeable to the dye, and become 
distinctive dark blue that can be differentiated and counted under a hemacytometer 
1 2 
(Magallanes et al , 2003). Detailed information about cell death can be further 
explored by staining with acridine orange, a metachromic dye which stains DNA 
and RNA in yellowish-green, while the cytoplasm in orange after being 
differentiated by calcium chloride. Because of its metachromic properties, apoptotic 
bodies, a special feature of apoptosis, can easily be recognized (Liu et al., 2006). 
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2.2. Materials and methods 
2.2.1. Cell culture 
Human colorectal cancer HT29 (HTB-38) cell line, which was obtained from 
the American Type Culture Collection (Rockville, MD, USA), was maintained in 
RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS, Life 
Technologies, Inc, Grand Island, N.Y., USA), 2 mM L-glutamine (Sigma, St. Louis. 
MO, USA), 100 lU/ml penicillin (Sigma), and 100 ^ig/ml streptomycin sulfate (Life 
Technologies). For experimental treatments, HT29 cells were seeded overnight to 
allow cell adherence, synchronized by serum depletion for 24 hr, and replenished 
with serum again for restarting the cell cycle 2 hr before all treatments. The seeding 
density for all experiments were kept at 2 x lO* cells/well in the 96-well plates, 5 x 
104 cells/well in the 4-well plates, 1.3 x 10^ cells/well in the 12-well plates, and 2 x 
10^ cells in the 10-cm diameter plates. 
Normal human skin fibroblast, a general gift from German Cancer Research 
Center, was cultured in the DMEM medium supplemented with 10% fetal bovine 
serum, 100 lU/ml penicillin (Sigma), and 100 |ig/ml streptomycin sulfate. For the 
MTT assay, 0.5 x lO* cells/well were seeded into the 96-well plate for adherence 
before challenging with ascorbates. 
2.2.2. MTT assay 
The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay is a colorimetric assay to determine the cell viability and the drug cytotoxicity. 
After seeding the cells in a 96-well culture plate overnight, cells were subsequently 
synchronized for 24 hr before challenged with a twofold dilution of SAA/SBA 
(general gifts from Prof. Hiroshi Sakagami of Meikai University School of Dentistry, 
Japan and Dr. Kochi M. of Ichijokai Hospital, Japan) for 1 or 2 hr, washed twice 
with PBS, and cultured again in culture medium for a total of 24 hr before subjected 
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to the MTT assay. Briefly, 10 |xl of the 5 mg/ml stock MTT solution was added to 
each well and incubated for 2 hr at 37°C for the production of purple formazan 
which were dissolved by DMSO before the absorbance of the formazan was 
measured at a wavelength of 570 nm using a 96-well microplate reader (Model 680， 
Bio-rad Lab., Inc., Japan). Data represented the results of triplicate samples were 
measured in each experiment. Three independent experiments were performed for 
each tested compound. 
Cytotoxicity 0/0=1- Absorbance (Abs) of treated cells 乂 購 � / � 
Abs of untreated cells 
2.2.3. Trypan blue exclusion assay 
After SAA or SBA treatment for 2 hr, synchronized HT29 cells were detached 
from the culture plates at the 4出 and 32""^  hours of the cell cycle (4h and 32h, 
respectively). The cell suspensions were mixed with 0.2% trypan blue solution in a 
1 ： 1 dilution, and the cell numbers were counted; cells in blue were counted as dead 
while unstained cells were alive. 
For the cytotoxic effect of continuous SBA administration study, synchronized 
HT29 cells were challenged 2 hr with 10 mM SBA every 12 hr for a total of 4 times, 
the cell viability was determined immediately after each administration. 
% Viability = 1-(dead cells/ total number of cells) x 100% 
2.2.4. Acridine orange staining 
HT29 cells seeded on the 13-mm round cover slips and treated with SAA/SBA 
for apoptotic features observation were fixed in ice cold 70% alcohol for 5 min at 
room temperature. They were subsequently stained with 0.01% acridine orange (AO, 
Sigma) in 0.06 M phosphate buffer (pH=6.0), differentiated with 0.1 M calcium 
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chloride (Sigma), and mounted with phosphate buffer on glass slides for observation. 
The images were captured using a fluorescence microscope (Axioskop, Ziess, 
Germany) with a 520 nm barrier filter and a 450-490 nm excitation block filter. 
2.2.5. Clonogenic assay 
After 2 hr-treatment with 10 mM SAA or 10 mM SBA, HT29 cells were 
trypsinized and resuspended at 5 x 10^ cells/ml in culture medium containing 0.3% 
noble agar (Sigma), and plated over the bottom layer with 0.5% Noble agar 
dissolving in culture medium in a 6-well culture plate. After 10 days incubation at 
37 °C，colonies were observed, measured and counted under an inverted microscope 
(Nikon, Tokyo, Japan). 
2.2.6. Statistical analysis 
Data were analyzed by one-way analysis of variance, followed by Duncan's 
multiple range test to detect intragroup (intergroup for 2-way analysis) differences 
using GraphPad Prism software 5.0 (USA). Significant difference was considered 
when *p<0.05 and ***P<0.001. 
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2.3. Results 
2.3.1. The cytotoxic effects of SAA and SBA 
The MTT assay was carried out to determine the dose-dependent and 
time-dependent effects of both ascorbates, ranging from 0-20 mM ascorbates for 1 
or 2 hr, in HT29 cells. Figs. 2.1 a & b show that both ascorbates increased their 
cytotoxic effects in a dose- and time-dependent manner, from 30% in 1 hr (Fig. 2.1 a) 
to around 50% and 40% in 2 hr for 20mM SAA and SBA-treated cells, respectively 
(Fig. 2.1 b). Since the cytotoxicity of lOmM SAA and SBA during the 2 hr-treatment 
was most obvious and there was a significance difference (p<0.05), comparative 
studies between SAA and SBA in the following chapters were restricted on this 
condition. As MTT can be easily converted to formazan by reducing agents, e.g., 
SAA (Bruggisser et al., 2002) that might result in false positive signals, trypan blue 
exclusion test for viable cell counts was employed to check whether the result of 
MTT assay was due to the interference by the SAA. Immediately after the 2-hr 
treatments, both ascorbates at 10 mM SAA or 10 mM SBA killed around 20% of the 
cells (Fig. 2.2，p < 0.001), and the survivors continued to grow for 1 more cell cycle 
(3Oh for 1 cell cycle) (see Fig. 4.3 b, Chapter 4) and ultimately reached about 70% 
and 80% (p < 0.05) of the normal untreated cell numbers in SAA and SBA-treated 
samples, respectively (Fig. 2.2). These cell count data confirmed the results of the 
MTT assay that SAA was more toxic than SBA by 10% after a 2-hr exposure 
treatment. 
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Figure 2.1. The cytototoxic effects of SAA and SBA on HT29 cells. HT29 cells 
werejncubated with SAA or SBA in a serial dilution (0 - 20 mM) for 1 
(a) or 2 hr (b) and then re-cultured without ascorbates for a total of 24 
hr. The cytotoxicity at each point was determined by the MTT assay 
described in the Material and Methods (Section 2.2.2) and the values 
are the mean 士 SD of triplicate experiments. 
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Figure 2.2 The cytotoxic effects of SAA and SBA on HT29 cells. The HT29 cells 
were treated with either 10 mM SAA or 10 mM SBA for 2 hr, and the 
viable cells were counted using trypan blue exclusion assay at 4h or 
36h of the cell cycle. Values denote the mean 士 SD of triplicate 
experiments. 
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2.3.2. Cell death induction by ascorbates 
Apoptotic body formation is a characteristic feature for apoptotic cell death that 
was easily stained in the nucleus by fluorescent dye, acridine orange. Fig. 2.2 show 
that about 20% of treated cells died after 2 hr SAA or SBA treatment, but no 
apoptotic bodies were observed (Figs. 2.3 b & c)，these results implicated that other 
types of cell death, e.g., necrosis and/or autophagy but not apoptosis, were triggered 
by both ascorbates. Prominent mitotic figures were observed in the untreated control 
cells (Fig. 2.3 d) which had already entered the G2/M phase at 26h of the cell cycle 
(data showed in Chapter 4), but not in the SAA or SBA-treated cells (Figs. 2.3 e & 
f ) . 
Control 10 mM SAA 10 mM SBA 
CeU cycle i f S y fe^Qfl H K ^ 
(a) (b) (c) mmm 
26 B I B m i B t l t K 
(d) (e) (f) 
Figure 2.3. Kinetic analyses of apoptosis following SAA or SBA treatment. The 
apoptotic bodies were monitored after a 2-hr short-term treatment with 
10 mM SAA (b & e) or 10 mM SBA (c & f). At the indicated time (4h 
or 26h) of cell cycle, cells were fixed, stained with acridine orange for 
apoptotic body observation, and viewed by the fluorescent microscope. , 
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2.3.3. Effects of ascorbates on the survival of HT29 cells 
Ten days after treatment with either SAA or SBA, there was small difference in 
colony numbers between the untreated control cells (Fig. 2.4 a) and the SBA-treated 
cells (Fig. 2.4 c), but these colonies were significantly more and larger than those of 
the SAA-treated samples (Fig. 2.4 b). The colonies with the diameter >75^im were 
counted and there was a significant difference in the clonogenicity (p < 0.001) 
between the control (94)，SAA (7) and SBA-treated (64) samples (Fig. 2.4 d). These 
results showed that the survivors in the SBA-treated group were able to grow and 
appear to catch up with the growth rate of the control cells, while only part of the 
SAA-treated cells were able to grow but likely in a slower manner . . 
f 
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Figure 2.4. Effects of ascorbates on the survival of HT29 cells. The proliferation of 
treated-HT29 cells was accessed by soft-agar clonogenic assay 10 days 
after 2 hr-treatment with either lOmM SAA or lOmM SBA. The 
colonies of the untreated control (a) SAA-treated (b) and the 
SBA-treated (c) samples were counted, the number of colonies 
(diameter >75 |xm) were presented in the (d). The data shown are the 
representatives of three independent experiments. 
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2.3.4. Applicabilities of ascorbates on human body 
In order to examine the applicability of SAA and SBA as a chemotherapeutic 
agent on human body, normal human skin fibroblasts were treated with both 
ascorbates at 0 - 40 mM. A similar level of cytotoxic effects (<20% at 5mM) by 
SAA ranging from 1.25 - 5 mM was found on both fibroblasts and HT29 cells, but 
the cytotoxicity to fibroblasts significantly increased (p < 0.001) to around 80% at 
10 mM which was much higher than that on HT29 cells (around 40%). On the 
contrary, the cytotoxicity of SBA on fibroblasts was far weaker than that of SAA, 
killing only 5% of fibroblasts and 20% of HT29 cells at 10 mM (Fig. 2.5). These 
results indicated that SBA is much suitable for the treatment of colon cancer HT29 
cells as it did not cause particular harm to normal cells even though its cytotoxicity 
on HT29 cells was also weaker. 
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Figure 2.5. The comparative study of the cytotoxic effects of SAA and SBA in 
normal human skin fibroblasts and HT29 cells. Fibroblasts and HT29 
cells were challenged with a serial dilution (0-40mM) of SAA or SBA 
for 2 hr and cultured in normal growth medium for total 24 hr. The 
cytotoxicity at each point was determined by the MTT assay described 
in the section 2.2.2, Material and Methods, and the values are the mean . 
土SD of triplicate samples. ‘ 
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2.3.5. The inhibitory effect of continuous SBA administration 
Previous data showed that the size of an inoperable human lung carcinoma 
reduced to only 2.7% of its initial volume with 71 days of SBA intravenous 
administration (2 g twice a day) (Sakagami et al., 1991); therefore, I speculated 
whether continuous SBA administration on HT29 cells could have similar outcome. 
During the course of repeated administrations, the cell numbers of SBA-treated 
group significantly dropped from 0.46 x 10^ to 0.32 x 10^  (p < 0.05), while the 
control group significantly increased from 0.35 x 10^  to 1.0 x 10^  (3-fold of the 
SBA-treated group, p < 0.05) (Fig. 2.6 b). Moreover, the cytotoxicity of SBA 
increased from 16% to 25% (Fig. 2.6 a). These results confirmed previous clinical 
studies that chemotherapy can be achieved by continuous SBA administrations. 
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Figure 2.6 The changes of cytotoxicity and cell number after continuous SBA 
«‘ 
administration. For every 12 hr, cells were left untouched or challenged 
with 10 mM SBA 2 hr for a total of 4 administrations, the cytotoxicity 
(a) and the cell number (b) were conducted by the trypan blue 
exclusion assay. Values are the mean 士SD of triplicate samples. 
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2.4. Discussion 
SBA, a benzaldehyde derivative isolated from the figs, has shown its in vivo 
and in vitro anti-tumor activities against human inoperable lung carcinoma, mice 
hepatocellular carcinoma, human promyelocytic leukemic HL60 cell line (Sakagami 
et al , 1991 & 1999) and human submandibular gland carcinoma HSG cell line (Fujii 
et al., 2003). In order to evaluate the cytotoxic effects of SBA on human colon 
adenocarcinoma HT29 cells, a short-term treatment with SBA, ranging from 1.25 -
20 mM, was applied in this study for a direct comparison with SAA. The results 
indicated that both ascorbates killed and inhibited the growth of HT29 cells in a 
dose- and time-dependent manner. The cytotoxicity of 20 mM SAA was 28% and 
54%, while 20mM SBA was 29% and 43% for 1- and 2-hr exposure, respectively 
(Fig. 2.1). The MTT results in Fig. 2.1 show that HT29 cells are more sensitive to 
SAA than SBA treatment. In consistent with the MTT assay, the trypan blue 
exclusion test also showed that the cell numbers of SAA and SBA-treated samples 
were around 70% and 80% of the control, respectively (Fig. 2.2), and the stronger 
cytotoxicity of SAA rendered only few colonies than SBA 10 days after treatments 
(Figs. 2.4 b & c). 
Previous reports showed that SAA and SBA could trigger apoptosis in different 
cell lines, e.g., human prostate carcinoma LNCaP and DU-145 cell lines (Maramag 
et al., 1997)，and human promyelocytic leukemic HL60 cell line (Sakagami et al , 
1991). This was, however, not the case in the present study when the colon cancer 
HT29 cells treated either with SAA or SBA were stained by acridine orange for the 
identification of apoptotic bodies (Figs. 2.2，4 h; 2.3 b & c)，and other types of cell 
death, e.g., necrosis and autophagy may be elicited. In the following chapters, details 
about the fate of SAA and SBA-treated cells will be described. 
Although SBA has lower therapeutic value than SAA in terms of cytotoxicity . 
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(Figs. 2.1 & 2.2) and anti-proliferation ability (Fig. 2.4), SBA is much applicable to 
human body as it does not cause remarkable harm to normal fibroblasts (Fig. 2.5) 
while SAA does. Furthermore, continuous SBA administrations (10 mM, twice a day) 
not only inhibited the cell growth, but also increased the sensitivity of cells to SBA 
treatment which increased from 16% at initial administration to 25% after the 
administration (Fig. 2.6). These results agreed with the previous findings that i.v. 
administration of SBA for 71 days could reduce the size of lung carcinoma to only 
2.7% of the initial volume (Sakagami et al., 1991). If longer period of continuous 
administration is carried on HT29 cells, the possibility of lower viability of HT29 
might be obtained. 
( 
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Chapter 3 Comparative studies of SAA and SBA in oxidative stress induction 
and their corresponding ROS inhibitors. 
3.1. Introduction 
3.1.1. Consequence of oxidative stress 
ROS has been of interest for many years in all areas of biology because of its 
importance in cell growth, differentiation and death by initiating a number of 
cellular signaling pathways. Being the secondary messenger in the cellular signal 
transduction, ROS alters a number of redox sensitive enzymes which are critical in 
cellular activities, e.g., mitogenesis, cell adhesion, oncogenic transformation, and 
apoptosis (Genestra, 2007). For example, oxidation alters the function of redox 
sensitive protein kinase PDK and phosphatase PTEN which are responsible for a 
battery of protein phosphorylations and result in carcinogenesis (Covey et al , 2007). 
Therefore, redox homeostasis has to be maintained to ensure proper cellular signal 
transductions. 
The balance between the production and consumption of ROS (Reactive 
oxygen species) and RNS (Reactive nitrogen species) is maintained by various 
systems in the cell. In the normal physiological conditions, both enzymatic and 
non-enzymatic defenses including glutathione peroxidase (GPx), superoxide 
dismutase, ascorbic acid and glutathione contribute to the oxidation-antioxidation 
balance and maintain the redox homeostasis (Cadenas, 1997). Any overproduction 
of ROS and/or RNS causes damage in cellular structures including protein, lipid and 
DNA, triggers cell cycle arrest, apoptosis and necrosis (Nair et al., 2004; Ueda et al , 
2002; Valko et al., 2007), and results in pathogenesis, e.g., atherosclerosis, 
myocardial failure, Alzheimer (Elahi et al , 2007; Loh et al., 2006). For example, the 
oxidation and accumulation of brain proteins, e.g., fibrinogen, precursor, a-l-antitypsin 
precursor, creatine kinase B and P-actin (Castegna et al., 2002; Choi et al, 2002) might ‘ 
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affect cell growth, differentiation and ultimate pathogenesis of Alzheimer's disease. 
3.1.2. Monitoring of oxidants production 
Two membrane permeable stains, 2,7-dichlorofluorescin diacetate (H2DCF-DA) 
and 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM-DA), 
were chosen to monitor the production of ROS and RNS in the viable cells. 
H2DCF-DA and DAF-FM-DA are capable of emitting fluorescent signals between 
517-527nm when they react with oxidants and nitrogen oxides, respectively. 
Increases in the fluorescent signals of H2DCF-DA and DAF-FM-DA reflect 
increasing ROS and RNS production. 
3.1.3. Oxidative and carbonylated modification of intracellular proteins. 
Carbonylation of proteins involves the production of carbonyl groups 
(aldehydes and ketones) on protein side chains (especially in proline, arginine, lysine 
and threonine residues) after exposure to ROS that results in rapid structural change 
and malfunction (Dalle-Donne et al , 2003). Carbonylated proteins are thus one of 
the biomarkers for reflecting oxidative damage because carbonyl groups are readily 
formed during oxidation, and remain stable for detection (Dalle-Donne et al., 2003). 
Derivation of carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH) forms a 
hydrazone derivative of carbonyl which is in a state that can be quantified by various 
methods, e.g. spectromphotometric DNPH assay coupled to protein fractionation by 
HPLC, enzyme-linked immunosorbent assay, and two dimensional-isoelectric focus/ 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (2D-IEF/SDS-PAGE) 
with immunoblotting coupled to mass spectrometry (Dalle-Donne et al., 2003). 
Among different methods, 2D-IEF/SDS-PAGE provides a more sensitive and 
accurate approach to access oxidized proteins (because of high resolution of 
2D-IEF/SDS-PAGE, specificity of antibody that recognizes DNP portion of ‘ 
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hydrazone, and the accuracy of the mass spectrometry). 
3.1.4. Hsp70 expression in response to oxidative stress 
During heat shock, a set of highly conserved proteins up-regulates rapidly and 
interacts with denatured or nascent proteins to prevent irreversible aggregation, and 
to catalyze the refolding of their substrates in an ATP and co-chaperone dependent 
manner. As they are commonly found after heat shock, this set of proteins is known 
as heat shock proteins (Hsps)/ chaperones which are further divided into four 
families according to their molecular weight: HsplOO, Hsp90, Hsp70 and small Hsps 
(Morcillo et al.，1997). 
Oxidation resulted in the formation of large amount of incorrect disulfide 
bridges which distort the conformation of proteins, therefore, binding of misfolded 
proteins with Hsps are urged to restore the folding and functions of the damaged 
proteins (Papp et al., 2003). During oxidative stress, up-regulated Hsp70 reversibly 
translocates form the cytoplasm to the nucleus, binds to the oxidized proteins 
(Bachelet et al., 2002), and passes them to endoplasmic reticulum (ER) for refolding. 
It is important to restore the structure and function of protein by refolding as the 
accumulation of oxidized proteins stresses the cells and induces cell cycle arrest or 
even cell death (Hosako et al., 2004). 
f 
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3.2. Materials and methods 
3.2.1. Reactive oxygen species (ROS) or reactive nitrogen species (RNS) 
detection 
HT29 cell were preloaded with either 10 |iM 2,7-dichlorofluorescin diacetate 
(H2DCF-DA, Molecular Probes, Inc., Eugene, Or, USA) or 5 i^M 
4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM diacetate, 
Molecular Probes) in PBS for 15 min at 37°C for the detection of intracellular ROS 
or RNS, respectively. After treatment with SAA or SBA in growth medium for 2 hr, 
HT29 cells were then trypsinized, centrifuged, re-suspended in ice cold PBS for 
intracellular ROS or RNS measurement by flow cytometry (Coulter ALTRA^*^ flow 
cytometer, Beckman Coulter, Inc., Miami, FL, USA) with excitation at 488nm and 
emission at 520nm, and the results were analyzed using Expo II software version 1.0 
(Beckman Coulter). For inhibiting ROS/RNS from SAA and SBA treatment, cells 
were firstly pre-treated with oxidase inhibitors, included 1 \iM diphenyleneiodonium 
chloride (DPI, Sigma) for 2 hr, 5 |iM rotenone (Sigma) for 2 hr, 10 |iM oxypurinol 
(Sigma) for 1 hr, 10 mM N-acetyl-L-cysteine (NAC, Sigma) for 2 hr, or 500 |xM 
7VorNitro-L-arginine methyl ester hydrochloride (L-NAME, Sigma) for 24 hr, and 
these inhibitors and scavengers co-cultured with SAA or SBA for another 2 hr. On 
the other hand, no pre-treatment was required for 1000 U/ml catalase (Sigma) and 
150 U/ml superoxide dismutase (SOD, sigma), catalase and SOD were only needed 
to culture with cells during SAA or SBA treatment. 
I 
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3.2.2. Immunoblotting analysis of protein-bound carbonyl groups by 
ID-SDS-PAGE and 2D-IEF/SDS-PAGE 
Nuclear proteins were extracted from treated and untreated HT29 cells using a 
ProtenExtract™ Subcellular Protemoe Extraction Kit (Calbiochem, Temecula, CA, 
USA) and separated by either ID-SDS-PAGE or 2D lEF/SDS-PAGE. The protein 
concentration in the cell lysate was assayed by BCA protein assay kit (Pierce 
Biotech., Inc., Rockford, IL, USA) 
For ID-SDS-PAGE, 10 \ig of protein lysate per lane was separated on a 12% 
polyacrylamide gel, transferred onto the PVDF membrane (Roche Diagnostics 
Corporation, Indianapolis, IN, USA) using a semi-dry Trans-Blot SD cell (Bio-rad, 
USA). The carbonyl groups of the oxidized proteins were derivatized according to 
the procedures of Conrad et al (2001) with a slight modification. PVDF membranes 
were activated in 100% methanol for a few seconds, dried at room temperature, and 
re-wet again by soaking in 20% methanol- 80% Tris buffered saline (TBS, 20 mM 
Tris base, 137 mM sodium chloride, pH=7.6). Derivatization with the incubation of 
0.5 mM DNPH (Sigma) in 2N HCl was followed by subsequent washes with 2N 
HCl 3 times and 100% methanol 5 times. After non-specific blockage (5% milk, 
0.05% Tween-20 in TBS), membrane was incubated with primary rabbit 
anti-dinitrophenyl-KLH (Molecular Probes) overnight in blocking buffer at 4°C, and 
followed by incubation with secondary HRP conjugated polyclonal anti-rabbit IgG 
(DakoCytomation, Glostrup, Denmark) for 1 hr at room temperature. Immunoblots 
were visualized by Lumi-Film Chemiluminescent Detection Film (Roche 
Diagnostics Corporation) using ECL™ Western Blotting Analysis System 
(Amersham Pharmacia Biotech, Piscataway, NY, USA). 
For 2D-IEF/SDS-PAGE, approximate 50 i^g of proteins were loaded onto a 
rehydrated Immobilized DryStrip pH gradient (IPG) strip (7 cm, pH 4-7，Amersham ‘ 
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Pharmacia Biotech, Piscataway, NJ, USA) and electrofocused in an Ettan IPGphor 
Isoelectric Focusing Unit (Amersham Pharmacia biotech). As oxidized proteins 
were mainly found within the isoelectric points ranging from pi 4.7 to pi 5.5 with 
molecular weights ranging from 45 to 90kDa (Choi et al, 2002), DryStrip pH 4-7 
was chosen in this study. After electro focusing, strips were equilibrated in the 
equilibrium buffer (6M urea, 75mM Tris-HCl, pH8.8，29.3 % (v/v) glycerol, 2% 
(w/v) SDS) with 10 mg/ml DTT for 10 min, and then replaced with 25 mg/ml 
iodoacetamide in equilibrium buffer for another 10 min. Strips were equilibrated 
again in equilibrium buffer before second dimension separation of proteins was 
performed on a 12% polyacrylamide gel. The separated proteins were transferred 
onto the PVDF membrane using a semi-dry transfer for derivatization system 
according to the procedures as described in method for the ID-SDS-PAGE. 
3.2.3. Immunofluorescence microcopy 
After appropriate treatments, cells were fixed in diethyl ether: ethanol in 1:1 
ratio (v/v) for 15 min before reacting overnight with 2-4dinitrophenyl- hydrazine 
(DNPH, Sigma) in 95% ethanol acidified with 1.5% (v/v) concentrated H2SO4. After 
reaction, cells were washed extensively with PBS to remove remaining DNPH. Cells 
were then blocked with 10% horse serum for 1 hr, incubated with anti-DNPH 
antibody (Molecular Probes) anti-rabbit biotinylated IgG antibody conjugated with 
Cy2 (Jackson ImmunoResearch Lab., Inc., West Grove, PA, USA), and mounted 
with SlowFade™ anti-fade solution (Molecular Probes). 
For the immunolocalization of Hsp70, cells were fixed in 100% methanol for 
15 min at -20°C, and were permeablized at room temperature (RT) with 0.2% triton 
X-100 for 10 min after twice washes in PBS. The cells were blocked in 2% bovine 
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serum albumin (BSA) for 30 min and incubated with antibody against Hsp70 
(Stressgen Bioreagents, Crop., Victoria, BC, Canada) antibody overnight at 4°C. 
Bound antibodies were subsequently detected by incubation with secondary 
antibody conjugated against Alexa-594 (Invitrogen Corp., Eugene, Oregon, USA) 
for 1 hr in 2% BSA. Finally, cell nuclei were counterstained with DAPI, mounted 
with anti-fade solution (Molecular Probes) and analyzed by confocal laser scanning 
microscope (Olympus, Tokyo, Japan, FVIOOO). 
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3.3. Results 
3.3.1. Intracellular ROS production 
In the comparative studies of their pro-oxidant properties, both SAA and SBA 
induced higher levels of intracellular ROS in HT29 cells than control cells. In spite 
of a short incubation period, SBA triggered around 7 fold higher intracellular ROS 
than SAA (SBA vs. SAA vs. control = 25% vs. 3.5 % vs. 1%) within 1 hr treatment 
(Fig. 3.1 a). Proceeding the ROS experiments with various oxidase inhibitors and 
antioxidants, DPI, rotenone, oxypurinol, L-NAME, NAC and catalase were chosen 
for studying the sources of oxidants production, particularly the cellular oxidant 
generating compartments. ROS induction in SBA-treated samples was partially 
lowered by pre-treating cells with DPI (-20%), rotenone (-50%), L-NAME (-35%) 
and NAC (-85%), but not with oxypurinol and catalase (Fig. 3.1 b), indicating 
NADPH oxidase, mitochondia and NOS were involved in SBA-triggered oxidative 
stress while xanthine oxidase and H2O2 were not. Among those effective oxidase 
inhibitors and antioxidants, NAC was the most effective in lowering the ROS 
generation by SBA. On the other hand, the amount of ROS was reduced to normal 
(Fig. 3.1 b) when cells were co-treated with both SAA and 1000 U/ml catalase; this 
result agrees with the common belief that the release of H2O2 by SAA treatment can 
be converted by catalase to non-toxic H2O and O2. Taken these results together, 
SBA is a stronger oxidant inducer and this oxidative stress is NAC-inhibitable while 
that from SAA is inhibited by catalase. 
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Figure 3.1. Kinetic analysis of the production of intracellular ROS by either 
10 mM SAA or 10 mM SBA treatment was accessed by staining live 
cells with H2DCF-DA and quantifying mean fluorescence by flow 
cytometer. HT29 cells were treated for 1, 2，and 4 hr prior to 
measurement (a). Effects of ROS inhibitors in the ROS production 
triggered by 2 hr-SAA or SBA treatment (b). Cells were pre-treated 
.. with 1 i^M DPI, 10 i^M OXY, 5 ^M ROT, 10 mM NAC, 500 |iM 
L-NAME or 1000 U/ml CAT prior to the SAA or SBA treatment. 
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3.3.2. Immunofluorescence microscopy, ID-SDS-PAGE and 2D-IEF/SDS-
PAGE immunoblotting analysis of carbonylated proteins 
In consistent with a higher level of intracellular ROS induced by SBA 
treatment in HT29 cells, microscopic images, ID-SDS-PAGE and 
2D-IEF/SDS-PAGE immunoblotting analyses also demonstrated the oxidized 
protein contents in the SBA-treated cells were more abundant (Figs. 3.2 - 3.4). The 
immunofluorscence microscopic analysis of oxidized proteins showed SBA-treated 
samples were more prominent than those of SAA-treated samples (Figs. 3.2 d vs. 3.2 
b). After appropriate co-treatments with catalase or NAC, the oxidized protein 
contents were lowered in SAA or SBA treatment, respectively (Figs. 3.2 c & e). 
Both Pleshakova et al., (1998) and Wondrak et a l , (2000) had pointed out that 
protein oxidation did not restrict to cytoplasmic protein, nuclear proteins, e.g., 
histone, are also possibly oxidized in vivo and in vitro via radiation or H2O2 
administration. In SBA-treated samples (Fig. 3.2 d), nuclear proteins (indicated with 
white arrows) were oxidized besides the cytoplasmic proteins. This observation was 
proved by immunoblotting analysis using antibody against the hydrazone derivative 
of carbonyl in nuclear proteins lysates (Fig. 3.3 a), showing SBA induced 2-fold 
higher of oxidized proteins than SAA did (Fig. 3.3 a, lane 1-3). In consistent with 
the previous findings in ROS detection by flow cytometry (Fig. 3.1 b) and 
immunofluorescence microscopy (Fig. 3.2 e), co-treatment with SBA and NAC 
reduced the amount of oxidized protein in SBA-treated samples to the level of 
untreated control samples (Fig. 3.3 a, lane 4-6). Those oxidized proteins shown in 
ID-SDS-PAGE were further analyzed by 2D-IEF/SDS-PAGE to find out their 
possible identities. From the pictures of 2D-IEF/SDS-PAGE, those up-regulated 
oxidized proteins (Fig. 3.5, spot 1-5) may be structural proteins as the molecular 
weight and pi values of oxidized spots are close to the structural proteins 
(http://us.expasv.org/swiss-2dpage/viewer). In order to fully understand these 
oxidized proteins and their consequence, identifications of these oxidized proteins . 
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by mass spectrometry are needed. In a nutshell, carbonylation is primarily due to the 
oxidative stress by ROS as removal of ROS by catalase and NAC can lower the 
carbonylated protein contents in SAA or SBA-treated samples, respectively. In 
addition, both cytoplasmic proteins and nuclear proteins are susceptible to oxidation. 
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Figure 3.2 Oxidized proteins formation in the SAA and SBA-treated HT29 cells. 
The fluorescence microscopy demonstrated the oxidized proteins in 
control (a), 10 mM SAA (b), lOmM SAA with 1000 U/ml catalase (c)， 
10 mM SBA (d) and 10 mM SBA with 10 mM NAC (e). The oxidized 
nuclear proteins in SBA-treated sample were indicated with white 
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Figure 3.3 Immunoblotting analysis of the nuclear proteins oxidation after 
exposing cells with different treatments (a). One group of samples was 
challenged with either lOmM SAA or 10 mM SBA. The other group of 
samples was pre-treated with lOmM NAC before SAA or SBA 
treatment. The expression of nuclear oxidized proteins relative to actin 
was shown in panel (b). 
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Figure 3.4. 2D-IEF/SDS-PAGE oxyblot of nuclear proteins from control (a) and 
10 mM SBA-treated (b) sample. The region from 54 kDa to 97 kDa and 
from pi 5.0 to pi 5.5 in (a) and (b) were enlarged to facilitate 
identification of responsive proteins. Those responsive proteins are 
marked by circles and 5 proteins were identified with significant 
oxidation. ‘ 
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3.3.3. Involvement of Hsp70 
Certain pathogenesis of diabetes, atherosclerosis and neurodegenerative 
disorders are closely related to the accumulation of damaged proteins, therefore 
proper refolding or removal of those damaged proteins are crucial to the normal 
growth of the cells and the body (Hosako et al , 2004; Valko et al., 2007). Hsp70, a 
well-known chaperone, is up-regulated during oxidation and is required for 
transferring those damaged proteins to ER for refolding (Papp et al., 2003). Figs. 3.5 
a - d show that the expression of cytoplasmic and nuclear Hsp70 remained 
unchanged after SAA or SBA treatments, indicating Hsp70 was unlikely involved in 
refolding of the oxidized proteins in these cells. 
(a) H ^ ^ l (b) 
(c) H^^ll (d) H^H 
Figure 3.5. Subcellular localization and expression of Hsp70 in HT29 cells after 
SBA treatment. HT29 cells were either untreated (a & b) or treated with 
10 mM SBA (c & d) for 2 hr. After treatments, cells were fixed and 
stained with anti-Hsp70 antibody. The same cells were counterstained 
with DAPI to identify the nuclei (b & d). All images were captured at a 
magnification of SOX. 
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3.4.Discussion 
ROS likes a two-edge sword; it is not only an important secondary messenger 
participating in various cellular signaling pathways for cell growth, differentiation, 
etc., but also has a destructive role in cell cycle arrest, apoptosis and even necrosis 
(Ueda et al” 2002; Valko et al., 2007). Therefore, enormous therapeutic 
developments had tried to make good use of ROS for cancer curing (Carosio et al., 
2007; Hosako et al , 2004). SBA, a benzadehdye derivatives isolated from the figs, 
has shown its direct cytotoxic action against tumor cells by its pro-oxidant property 
for apoptosis induction in human myelogenous leukemic cell lines (Asano et al., 
2001). In order to elucidate the anti-tumor ability of SBA in detail, SAA, a 
well-known oxidant at pharmacological concentrations (0.3 - 20 mM, Chen et al., 
2005), was chosen to compare their oxidants generating ability, and their mode of 
anti-tumor actions. Structurally, SBA differs from SAA with benzaldyhyde addition. 
Although they have similar backbone, surprisingly, the magnitude of ROS 
production in SBA-treated HT29 cells was around 7-fold higher of that of SAA 
under a short term treatment (Fig. 3.1 a). Besides the magnitude of ROS production, 
the distinct oxidants generating pathways triggered by SAA and SBA were 
compared in the different experiments with various oxidase inhibitors and 
antioxidant. Catalase which is capable of detoxifying H2O2 can only lower the ROS 
generation by SAA. Other sources of oxidants induced by SBA were tested using 
NAC, rotenone, L-NAME, DPI, and oxypurinol. Referring to fig. 3.1 b, the ROS 
production in SBA-treated sample was partially reduced by DPI (18%), rotenone 
(40%), L-NAME (40%) and NAC (85%). These results suggested that the 
cytotoxicity of SAA was caused by extracellular induction of H2O2 as catalase 
cannot be imported into the cells, while that of SBA was caused by intracellular 
induction of oxidants which partially came from NADPH oxidase, mitochondria, 
NOS. This prediction was supported by the previous published data in which stated ‘ 
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that only 0.04% of SBA dissolved in culture medium was found within the cells 
(Sakagami et al , 1995); SBA may kill the cancer cells by releasing free radicals 
itself or triggering cell surface enzymes rather than a direct incorporation to the 
intracellular targets. 
When the cells are challenged with ROS, intracellular molecules, such as lipids, 
proteins and DNAs, are oxidized and become malfunction. As demonstrated in the 
confocal microscopic images (Figs. 3.2 b & 3.2 d), the overall amount of oxidized 
proteins in SAA- or SBA-treated samples were higher than in the untreated control 
samples (Fig. 3.2 a). Moreover, oxidized proteins in SBA-treated sample were more 
prominent than those in the SAA-treated samples; this observation is in consistent 
with the highest intracellular ROS induction after SBA treatment shown in Fig. 3.1 a. 
When the cells co-treated with their appropriate inhibitors (Catalase for SAA, NAC 
for SBA), the amount of oxidized proteins was greatly reduced. Apart from the large 
amount of oxidized proteins in the SBA-treated cells, nuclear protein oxidation was 
another prominent features (Fig. 3.2 e) that agree with the findings from 
Dalle-Donne et al. (2001) that actin cytoskeleton is susceptible to oxidation as it is 
one of the earliest targets of ROS in different mammalian cell types including 
human hepatocyte, human fibroblasts and human platelets. Predicting from the 
molecular weights and pis of oxidized spots shown in 2D-IEF/SDS-PAGE analysis, 
those nuclear oxidized proteins in current SBA treatment may be structural proteins 
such as p-actin, cytokeratin.. .etc. Protein identification using mass spectrometry 
will be performed to disclose their identities. 
In order to eliminate the cytotoxic effect of oxidized protein accumulation, 
different systems including chaperones, ER and proteasomes are responsible for 
proper removal or refolding of oxidized proteins. During oxidation, up-regulated 
Hsp70, a well documented chaperone, binds to the misfolded proteins in an 
( 
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ATP-dependent fashion and releases to ER for refolding (Renis et al., 2003). 
However, the expression level and localization of Hsp70 remained unchanged in the 
current study (Figs. 3.5 a - d), indicating Hsp70 was not involved in restoring 
protein structure. Since a cell fails to refold oxidized proteins, the consequences will 
be studied in the following chapters (see Chapter 5) • 
I 
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Chapter 4 Effects of SAA and SBA treatments on cell cycle regulatory 
proteins and the induction of transient cell cycle arrests in Gl, S 
and G2 phases 
4.1. Introduction 
4.1.1. Cell cycle 
The cell cycle is an ordered series of events leading to cell division and 
production of two genetically identical daughter cells. There are four discrete phases 
composing of the cell cycle, namely S phase (DNA synthesis), M phase (cell 
division), Gl and G2 phase (gaps between the S and the M phases, respectively). 
The Gl progression depends on sustained expression of D-type cyclins (cyclins Dl, 
D2 and D3), cyclin E, Cdk 2，Cdk 4 and Cdk 6 for the entry of DNA synthesis phase 
(S phase). Being stimulated by mitogenic factors, transcriptional induction of cyclin 
D onsets the Gl progression by c-myc, Ap-1 and NF-KB. Cyclin D binds and 
activates Cdk4/6 to become activated kinase, thereby phosphorylating 
retinoblastoma (Rb) protein which can no longer repress cyclin E transcription; 
cyclin E then binds to Cdk2 for promoting the entry of cells into the S phase 
(Ekholm & Reed, 2000). Without the participation of cyclin D, cell cycle arrest in 
the mouse fibroblast (Bamouin et al , 2002) and the death in the cyclin D-deficient 
[D1 (-/-)D2(-/-)D3(-/-)] mice because of the failure in the expansion of hematopoietic 
stem cells (Kozar et al., 2004) were resulted. However, over expression of cyclin D 
or E would also lead to premature entrance into the S phase in mammalian (Ohtsubo 
& Roberts，1993) and rodent fibroblasts (Quelle et a l , 1994). Therefore, accurate Gl 
progression requires proper expression of cyclin D. 
4.1.2. Regulation of p21 protein expression and intracellular localization 
The level of p21 protein in normal proliferating cells is low unless 
( 
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transcriptional induction by transcription factors, including p53, Spl/Sp3, and redox 
sensitive Ap-1 and Sp-1, in response to DNA damage, terminal differentiation and 
replicative senescence (Bonnstra & Post, 2004; Cartel & Radhakrishnan，2005; 
Russon et al., 1995). Over-expression of p21 protein arrests the cell progression 
transiently or even permanently at the Gl, S or G2 phase in a p53-dependent 
or -independent manner by binding to cyclin-Cdk complexes, and/or the 
proliferation marker, proliferating cell nuclear antigen (PCNA) (Gartel et al , 2005). 
The cell arrest mediated by p21 protein is important for efficient DNA repair as 
p21-deficiency cell lines, e.g., human p21-/- HCT116 colon cancer cell line, are 
defect in DNA repair and more sensitive to DNA damage by UV radiation 
(McDonald et al., 1996). 
Apart form the expression, subcellular location of p21 is also important in the 
regulation of cell cycle progression. It is well documented that cytoplasmic p21 
induced cell cycle progression in both in vitro and clinical studies after mild UV 
radiation (Winters et al , 2003). With the nuclear localization signal (NLS) within its 
DNA binding domain, p21 can translocate into the nucleus to regulate gene 
expression in response to genotoxic insults or oxidative stress, and the cells are 
consequently resulted in Gl or G2 arrest. If p21 protein is prevented from nuclear 
translocation by phosphorylation, cell cycle arrest is unable to be mediated (Zhou et 
al , 2001). 
I 
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4.1.3. Inhibition of cell cycle in response to oxidative stress 
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Figure 4.1. Schematic diagram showing the multitude effects of ROS on signal 
transduction and cell cycle progression (adopted from Boonstra & Post， 
2004). 
During oxidative stress, various cellular components, including DNA, lipid and 
proteins, are damaged. Depending on the amount of ROS, the duration of the ROS 
exposure, and the type of cells involved, transient or permanent cell cycle arrests 
will be resulted (Boonstra & Post, 2004). For example, sublethal dose of H2O2 
transiently arrested mouse NIH3T3 fibroblasts at the G1 phase (Bamouin et al.， 
2002)，but same amount of H2O2 could permanently arrest human fibroblasts at the 
G1 phase (Chen et al., 2000). In addition to its cell damage effects, ROS also acts as 
a secondary messenger to trigger various signaling pathways, it increased ERK and 
p38 phosphorylation which in turn down-regulated cdc25C expression in the 





In order to characterize the nature of cell cycle arrests, HT29 cells were 
synchronized at different phases by serum and glutamine depletion in the culture 
medium for blocking cells at the Gl phase, or double thymidine block method for 
inhibiting cells from entry into the S phase. Without the supplement of glutamine 
and growth factors from the serum, DNA synthesis is blocked, and the cells are 
restrained at the Gl phase. On the other hand, high concentration of thymidine used 
in double thymidine blockage causes over accumulation of thymidine triphosphate 
that prevents cell from entering the S phase for replication by inhibiting 
ribonucleotide reductase (Merrill, 1998). 
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4.2. Materials and methods 
4.2.1. Synchronization: serum deprivation and double thymidine block 
For cell cycle analysis, synchronization is required to accumulate a pool of 
cells in the particular phase of the cell cycle. Serum deprivation is commonly used 
to synchronize cells at the G1 phase. Cells were seeded at 3X1O^ cells/ml/well in a 
6-well culture plate overnight, rinsed with PBS twice to remove serum before 
continued to incubate in plain RPMI-1640 medium (Life Technologies) for 24 hr. 
About 85% of cells stayed at G1 phase against the 24 hr serum deprivation. Double 
thymidine block is another commonly used method to synchronize cells at the 
transition of the Gl/S phase. After seeding cells on culture plates overnight, cells 
were first treated with 2 mM thymidine (Sigma) for 17 hr, and then washed with 
PBS for 2 times, and cultured in growth medium for 9 hr before another 2 mM 
thymidine treatment for 14 hr. Almost all of the cells remained in the Gl/S 
interphase immediately after the double thymidine block, and -100% cells were in 
the S phase when the cells were released for 2 hr after the blockage. 
4.2.2. Flow cytometry for cell cycle analysis 
After appropriate treatment, cells were fixed in ice-cold 70% ethanol overnight, 
washed with PBS once, and incubated with PI solution (20 ^ig/ml PI, 0.1% Triton 
X-100 and 0.2mg/ml DNase-free RNase) at room temperature (RT) for 30 min. The 
content of DNA incorporated with PI was analysed using a flow cytometer 
(Beckman Coulter) with an argon laser at 488 nm. Approximate 10,000 events were 
acquired per sample, and each treatment was performed at least three times. Primary 
data analysis were performed with the Expo32 software, version 1.0 (Beckman 
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Figure 4.2. A typical DNA pattern of HT29 cells. The x-axis of the flow cytometric 
DNA histogram represents the DNA content while y-axis represents the 
relative cell number. The first peak represents the cells at the Gl phase, 
the second peak represents the cells at the G2 phase in which the 
double fluorescent content is equivalent to the double DNA contents in 
the G2 phase, while the area between these two peaks represent the 
cells at the S phase. 
4.2.3. Inhibition of cell cycle arrest by oxidant inhibitors 
Various inhibitors of oxidant generating enzymes or ROS scavengers were used 
to reverse the cell cycle arrest induced by SBA or SAA (Details about the 
concentrations and pre-treatment durations have been described in the previous 
chapter (see section 3.2.1., Chapter 3). After the 2-hr drug treatment, cells were 
washed clear of inhibitors, ROS scavengers and SAA or SBA with PBS twice, and 
followed by growing cells in supplemented culture medium for specific time points 
before cells were harvested, and fixed in ice cold 70% ethanol overnight for cell 
cycle analysis. The procedures of cell cycle analysis have been mentioned in section 
4.2.2. 
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4.2.4. Immunoblotting analysis of cell cycle regulatory proteins. 
Cells were seeded at 2.5 x 10^ cells/ml in a 10-cm dish overnight and then 
synchronized in plain RPMI medium for 24 hr prior to different treatments. Total 
proteins were extracted from treated cells with Tris lysis buffer (50 mM Tris-HCl, 
150 mM NaCl, 0.2% Triton X-100, 10 |ig/ml aprotinin, and 0.5 mM PMSF). They 
were then centrifuged at 13,000 rpm for 20 min to collect the supernatant containing 
the proteins and stored at -20 until immunoblotting analysis. The protein 
concentration in the cell lysate was assayed by BCA protein assay kit (Pierce 
Biotech.). 
50 |xg of protein lysates were subjected to SDS-PAGE for separation according 
to their molecular weight, and they were transferred onto a PVDF membrane (Roche) 
for immunobloting analysis using a semi-dry transfer system (Trans-Blot SD cell, 
Bio-Rad) at 1.2 mA/cm^ for 1 hr. After blotting, membrane was blocked with 1% 
gelatin (Sigma) for 1 hr in TBS/ 0.1% Tween 20 before incubation with primary 
antibodies (all primary antibodies were purchased from Santa Cruz biotechnology) 
at 4 overnight, and then with horseradish peroxidase (HRP)-conjugated 
polyclonal goat anti-mouse (Amersham Pharmacia Biotech.) or anti-rabbit 
immunoglobulin G (IgG) (Dako Cytomation), before the blots were developed with 
an enhanced chemiluminescence method (ECL, Amersham Pharmacia Biotech). For 
• reprobing with other antibodies, antibodies were stripped away by the Re-blot Plus 
Western Blot Recycling Kit (Chemicon International, Inc, Temecula, CA, USA). 
4.2.5. Immunofluorescence microscopy 
For the immunolocalization of the p21 protein, cells cultured on coverslips 
were fixed in 100% methanol for 15 min at -20 and permeablized at room 
temperature (RT) with 0.2% triton X-100 for 10 min after two washes in PBS. The 
cells were blocked in 2% BSA for 30 min, and then incubated with antibody against 
f 
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p21 protein (Santa Cruz Biotech., Santa Cruz, CA, USA) for overnight at 4 
Bound p21 antibody was subsequently detected by incubation with the secondary 
antibody conjugated with Cy2 (Jackson ImmunoResearch Lab.) for 1 hr in 2% BSA. 
Finally, slides with stained cells were mounted with anti-fade solution (Molecular 
Probes) containing 1 |ig/ml DAPI and analyzed using a confocal laser scanning 
microscope (Olympus, Tokyo, Japan). 
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4.3. Results 
4.3.1. Cell synchronization 
Synchronization of cells at the particular phase is important in the 
characterization of the nature of cell cycle arrest especially for transient cell cycle 
arrest studies. Following depletion of serum and glutamine in the culture medium, 
about 85% of HT29 cells were synchronized at the Gl phase because the growth 
factors in the serum and the glutamine are very important to initiate the cell cycle 
progression (Fig. 4.3). For the studies of drug-induced S phase arrest, the double 
thymidine block method is extensively utilized. Fig. 4.3 shows that cells were 
completely synchronized at the S phase and G2 phase, respectively, at 2 hr and 8 hr, 
respectively, after the cells were released from a double thymidine block. 
Estimated from the findings of Fig. 4.3，the duration of each phase was 20 hr, 6 
hr and 4 hr for the Gl phase to the S phase, the S phase to the G2 phase, and the G2 
phase to the Gl phase, respectively. 
I 24 hr after serum 
I / depletion 
I 2 hr after double 
J thymidine block 
I I \ ^ 8hr after double 
j thymidine block 
Figure 4.3. Cell cycle analysis of HT29 cells. Subconfluent cycling HT29 cells 
were harvested and fixed after 24 hr serum depletion, 2 hr or 8 hr after 
double thymidine blockage. The fixed cells were permeablized and 






30h \ / \ 
s I h 
\ 20h 18h，transition of j 
\ Gl/S, blocked by J 
j C . double thymidine y 
Figure 4.4. A schematic diagram showing the cell cycle profile of the HT29 cells at 
18h, 20h, 26h and 30h of the cell cycle. 
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4.3.2. SBA induced longer period of transient cell cycle arrest than SAA 
HT 29 cells were synchronized at either the Gl phase or the S phase by serum 
depletion or double thymidine block, respectively, and the short term effects of 
ascorbates on cell cycle progression were shown in fig. 4.6. The untreated HT29 
cells progressed normally to the Gl/S transition at 20h (the h of the cell cycle) 
and reached the late G2 phase at 28h of the cell cycle. Treatment of cells with 
10 mM SAA (Figs. 4.6 e - h) did not alter the entry of the cells into the G2 phase at 
28h of the cell cycle as compared with that of the untreated sample. Cells treated 
with 10 mM SBA for 2 hr remained at the Gl phase at 20h and enter the S phase at 
28h of the cell cycle (Figs. 4.6 i - 1); this result shows that SBA treatment induced a 
transient cell cycle arrest at the Gl phase, and delayed the cells from progressing 
into the S phase by 8 hr (Fig. 4.7 a). 
For an imminent analysis, the percentage of cells at the Gl, S or G2 phase in 
different samples were measured. At 20h, 13% of untreated cells, 27% of 5 mM 
SAA-treated cells, 47% of 10 mM SAA treated-cells, 35% of 5 mM SBA-treated 
cells, and 70% of lOmM SBA treated cells were in the Gl phase (Fig. 4.7 b). These 
results indicated that the cell cycle inhibition is dose-dependent for both ascorbates. 
Of the same concentrations, SBA exerted stronger Gl arrest in the HT29 cells (27% 
vs 35%; 47% vs 70% for 5 mM SAA vs 5 mM SBA; 10 mM SAA vs 10 mM SBA, 
respectively). For measuring the time of delay in cell cycle progression, figs. 4.7 a, b 
& c show that there is a lag of 8 hr for SBA-treated cells in leaving the Gl, S, and 
G2 phase, respectively. 
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Figure 4.5 Diagram illustrates the procedure for conducting the DNA pattern 
analysis of ascorbates treated-HT29 cells which were administrated 
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Figure 4.6 Cell cycle analyses of serum deprivation synchronized HT29 cells after 
SAA or SBA 2 hr-treatment. The cell cycle profiles of untreated HT29 
cells (a - d) at 4，12，20，28h of the cell cycle are showed in the left lane. 
The cell cycle statuses of lOmM SAA-treated and lOmM SBA-treated 
cells which were harvested at the same time points of the untreated 
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Figure 4.7 Cell cycle analyses of the HT29 cells after SAA or SBA treatment. 
HT29 cells were treated with 5 mM or 10 mM SAA/ 5 mM or 10 mM 
SBA for 2 hr, harvested and analyzed using a flow cytometer to 
measure the percentage of different cell population in the G1 phase (a), 
S phase (b) and G2 phase (c) at 12h, 20h, 28h and 36h of the cell c y c l e . ‘ 
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4.3.3. Oxidative pathways and cell cycle arrest 
A battery of oxidase inhibitors and anti-oxidants, including DPI, oxypurinol, 
rotenone, NAC, L-NAME and catalase, were used to study the mechanisms 
mediating the cell cycle arrest by SAA and SBA. Pre-treatment of cells with DPI, 
oxypurinol, rotenone and L-NAME failed to restore the cells from growth arrest 
induced by SAA or SBA. Catalase was successful to restore the DNA pattern of 
SAA-treated samples to that of untreated samples (Figs. 4.8 a & b), but it failed to 
resume the cell cycle in the SBA-treated samples (Fig. 4.8 c). On the other hand, 
pre-treatment with NAC could minimize the cell cycle inhibitory effect induced by 
SBA (Figs. 4.8 e & f)，but DPI, rotenone and L-NAME could not (Figs. 4.9 a - e). 
These data demonstrated that oxidative stress from short term treatments with SAA 
or SBA at a dose of 10 mM was sufficient to induce a transient growth arrest. 
Moreover, the source of oxidants by SAA or SBA is likely originated from different 
sources, and the transient cell cycle arrests induced by SAA or SBA can be inhibited 
by catalase or NAC, respectively. 
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Figure 4.8. Cell cycle analyses of the restoration of cell cycle arrest in lOmM SAA 
and SBA-treated HT29 cells by catalase or NAC. Cells were co-treated 
with 1000 U/ml CAT (a - c), or pre-treated with 10 mM NAC (d - f) 
before challenged with 10 mM SAA or 10 mM SBA for 2 hr. At 20h, 
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Figure 4.9 Cell cycle analyses of the restoration of cell cycle arrest in SAA and 
• SBA-treated HT29 cells by DPI, rotenone or L-NAME. Cells were 
pre-treated with 1 |iM DPI (a, b), S^M ROT (c, d) or 500 \iM 
L-NAME (e, f) before challenged with 10 mM SAA or 10 mM SBA 
for 2 hr. At 20h, cells were harvested and fixed in cold ethanol for 
DNA pattern analysis. 
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4.3.4. SBA triggered transient cell cycle arrest at Gl, S and G2/M phase 
To confirm whether SBA also triggered cell cycle arrests in the S and G2/M 
phases, HT29 cells were synchronized at the S and the G2 phases, respectively, 
before the SBA administration. Figs. 4.11 c & d, Figs. 4.13 c & d further show that 
SBA induced NAC-inhibitable cell cycle arrests in both S and G2/M phases. 
GO 
G2/M 
力 h \ 
/ Harvested samples \ 
s 
\ Pre-treated cells with / 
\ “ normal medium or / G l 
\ 20h / 
Treated cells with lOmM NAC / 
SBAfor2hr 
Figure 4.10 Diagram illustrates the procedure for conducting the DNA pattern 
analysis of SBA treated-HT29 cells which were administrated with 
lOmM SBA during the S phase. 
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Figure 4.11 Cell cycle analyses of the cell cycle inhibition effect of SBA in 
S phase-HT29 cells. At 26h of the cell cycle, untreated sample (a), 
sample treated with 10 mM NAC alone (b), 10 mM SBA-treated 
sample (c), and sample treated with both lOmM SBA and 10 mM NAC 
were harvested for DNA pattern analysis. 
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Figure 4.12 Diagram illustrates the procedure for conducting the DNA pattern 
analysis of SBA treated-HT29 cells which were administrated with 10 
mM SBA during the G2 phase. 
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Figure 4.13 Cell cycle analyses of the cell cycle inhibition effect of SBA in 
G2 phase-HT29 cells. At 3Oh of the cell cycle, untreated sample (a), 
sample treated with lOmM NAC alone (b), 10 mM SBA-treated sample 
(c), and sample treated with both 10 mM SBA and 10 mM NAC (d) 
were harvested for DNA pattern analysis. 
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4.3.5. Temporal up-regulation of p21 protein, down-regulation of cyclin D and 
PCNA proteins during the SBA-induced transient cell cycle arrest 
Since the SBA-mediated growth arrest is cell cycle-independent, imminent 
mechanistic studies were mainly focused on the Gl arrest. Protein lysates of both 
SAA- and SBA-treated cells were harvested at different time points for a kinetic 
studies of the expression of the Gl regulatory proteins, p21, cyclin D and PCNA, 
after a 2-hr treatment. Figs. 4.14 a and 4.15 b show an robust but transient 
expression of p21 protein, reaching a peak at 8h in SBA-treated cells, but the level 
of p21 was rather low in SAA-treated cells. The expression of cyclin D in 
SAA-treated cells at 4h is comparable to that of the untreated controls, while SBA 
treatment totally inhibited cyclin D expression (Fig. 4.14 b). The 
immimoprecipitation analysis of SAA- or SBA-treated cell lysates using antibody 
against p21, and the immunoblotting analysis with antibodies against p21 and cyclin 
D demonstrated that p21 expression in the SBA-treated lysate was 4-fold higher than 
that in the SAA-treated lysate, but equal amount of cyclin D was bound by p21 (Fig. 
4.16). These results indicated that low level of cyclin D was available in the 
SBA-treated cells for formation of inhibitory complex (i.e., p21-cyclin D-Cdk4/6). 
PCNA, a protein that binds p21 in Gl-arrested cells，was down-regulated in both 
ascorbate-treated samples at 4h but restored to the level similar to that of the 
untreated sample at 12h (Fig. 4.14 c). It was found that the reduction of PCNA 
expression in SAA-treated samples was more than that of SBA-treated samples. In 
addition, no active caspase 3 was detected in cells after all treatments, indicating that 
cell cycle arrest was not accompanied by apoptosis under the oxidative stress 
(Fig. 4.15 a). 
For the current increase of p21 transcription in p53-mutant HT29 cells, ROS but not p53 is 
the inducer as removal of ROS by ROS scavenger, NAC, the expression of p21 in SBA-treated 
cells was significantly reduced to the level of the untreated sample (Fig. 4.17, p <0.001). ‘ 
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Figure 4.14. Expression of cell cycle regulators of the G1 phase in HT29 cells 
following 2 hr treatment of lOmM SAA or lOmM SBA. Cell lysates 
were prepared from HT29 cells at the times indicated following 
treatment with SAA or SBA. The expressions of p21 (a), cyclin D (b) 
and PCNA (c) were analyzed by western blotting and the expression of 
cell cycle regulators proteins relative to actin was shown in panel (d). 
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Figure 4.15. Expression of p21 and pro-caspase 3 in HT29 cells during and after the 
treatment of lOmM SAA or 10 mM SBA. Cell lysates were prepared 
from HT29 cells at the times indicated during and after treatment with 
SAA or SBA. The expressions of p21 (a) and pro-caspase 3 (b) were 
analyzed by western blotting and the expression of cell cycle regulators 
proteins relative to actin was shown in panel (c). 
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Figure 4.16. Immunoprecipitation analysis of p21/ cyclin D complex formation 
with anti-p21 antibody. After treatment with lOmM SAA or 10 mM 
SBA for 2 hr, cell lysates were precipitated with p21 antibody, 
separated by SDS-PAGE and then detected by both p21 and cyclin D 
antibodies. 
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Figure 4.17. Inhibition of p21 protein expression from SAA and SBA-treated 
samples that were pre-treated with NAC or catalase. Before ascorbates 
treatments, HT29 cells were pre-treated with either 10 mM NAC or 
1000 U/ml catalase. After 2 hr SAA or SBA treatments, cells were 
fixed and the p21 protein was detected with FITC-conjugated p21 
antibody which was measured using a flow cytometer. 
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4.3.6. Nuclear localization of p21 in SBA treated cells 
Apart from the expression, the localization of p21 is more important for the 
onset of cell cycle arrest. During the cell cycle arrest, p21 translocates from the 
cytoplasm to the nucleus where it exerts its cell cycle inhibitory effects. Such 
nuclear p21 localization was demonstrated by immunofluorescence in the 
SBA-treated cells (Figs. 4.18 e & f) but not in the untreated (Figs. 4.18 a & b) or 
SAA-treated cells (Figs. 4.18 c & d). 
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Figure 4.18. Expression and localization of p21 expression in SAA- or SBA-treated 
HT29 cells. HT29 cells were challenged with 10 mM SAA (c & d), 
10 mM SBA (e & f), or left untouched (a & b) for 2 hr and then fixed 
for immunostaining. p21 was recognized with p21 antibody and 
subsequently stained with Cy2-conjugated secondary antibody, while 
the nuclei were counterstained with DAPI. All the confocal images 
were captured at a magnification SOX. 
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4.4. Discussion 
Results obtained from the flow cytometry and western blotting analysis 
showed that both short term treatments of SAA and SBA delayed cell cycle 
progression through the modulation of cell cycle regulatory proteins in a dose-
dependent manner. Higher dose (10 mM) of both SAA and SBA could inhibit the 
cell cycle more effectively than the lower dose (5 mM). Furthermore, the inhibitory 
effect of SBA was stronger than SAA at equimolar concentrations (Fig. 4.7). 
Co-treatment of cells with catalase and NAC can reverse the growth arrests 
induced by SAA and SBA, respectively (Figs. 4.8 b & f); these results agreed with 
the data demonstrated in Fig. 3.1 b in which catalase and NAC could lower the 
amount of ROS induced by SAA and SBA, respectively. The cell cycle inhibitory 
effects by SBA on the S and G2 phases were further investigated in synchronous 
cells by double thymidine block. The results in figs. 4.11 c & 4.13 c show that SBA 
also transiently inhibited cell progression at the S and the G2 phase which could be 
restored by NAC pre-treatment, similar to that of the Gl arrest (Fig. 4.8 f). Taken all 
flow cytometric data together, SBA induced cell cycle-independent arrest via a 
NAC-inhibitable pathway. The stronger inhibitory effect by SBA than SAA is likely 
caused by more ROS released by the SBA-treated cells; and thus ROS is the primary 
• inducer for the cell cycle arrest. 
As SBA induced multi-phase cell cycle arrests, the molecular mechanism(s) 
for such effects were studied in the Gl phase. During Gl arrest, Bamouin et al. 
(2002) and Strasberg et al. (1996) had showed the positive regulators, e.g., cyclin D 
and PCNA were reduced, while the negative regulators, e.g., p21 and p27 were 
increased. In the current study, Figs. 4.14 a - c show a reduction in cyclin D and 
PCNA induced by SAA, while SBA not only reduced those positive Gl regulators 
(cyclin D and PCD A) but also induced p21. These results agree with other reported 
studies that the Gl arrest is closely associated with the decreased expression of ‘ 
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cyclin D and PCNA, and increased expression of p21 protein. Moreover, the result 
of p21 protein expression showed that larger amount of p21 protein was required to 
delay the arrest in a longer period of time. The transcription of p21 can be triggered 
via p53-dependent or -independent pathways, but p21 transcription in this study is 
independent of p53 because the HT29 cells are p53-mutant colon cancer cell line 
(Howells et al., 2007). The current experiments cannot deduce whether other 
transcription factors, e.g., AP-1 and SP-1 (Boonstra & Post, 2004), are involved in 
p21 transcription, whereas the involvement of oxidation in p21 up-regulation is 
guaranteed as NAC pre-treatment lowered p21 expression level in SBA-treated 
samples (Fig. 4.17). Boonstra and Post (2004) had pointed out that large amount of 
ROS are sufficient to induce p21 up-regulation without activation of other 
transcriptional factors. 
In addition to the expression level of G1 regulatory proteins, the interaction 
and binding between p21 and cyclin D are also important in retarding the G1 
progression. Therefore, the binding of p21 to cyclin D/Cdk 4/6 complex was 
investigated in both SAA and/or SBA treatments besides the expression level of p21. 
Fig. 4.16 shows that similar amount of cyclin D was bound by p21 in both 
treatments for induction of G1 arrest. Suppression in cyclin D synthesis by oxidative 
stress (Ranjan et al , 2006) resulted in its low availability for formation of 
p21-cyclin D complex in the SBA-treated sample in comparison with SAA-treated 
samples. Apart from the expression levels, the inhibitory effect(s) of p21 protein is 
ensured when they are located in nucleus. Figs. 4.18 e & f show that large amount of 
p21 was translocated into the nucleus, further confirming that prolonged cell cycle 
arrest was enforced by p21 up-regulation and nuclear translocation during the SBA 
treatment. 
Permanent cell cycle arrest may be accompanied by apoptosis or necrosis. 
Since only a transient cell cycle arrest was triggered by SAA and SBA, apoptosis • 
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was not elicited. This assumption was confirmed by an absence of active caspase 3 
from a cleavage of the pro-caspase 3 protein in the cells treated with both ascorbates 
as shown in the western blotting analysis (Fig. 4.15 a). 
In conclusion, the short term oxidative stress induced temporal induction of 
p21, reduction of cyclin D and PCNA, that resulted in a transient Gl cell cycle arrest 
but not apoptosis in the SAA or SBA-treated HT29 cells. This cell cycle arrest was 
not only restricted to the Gl phase but also to other phases, including S and G2 
phases, after a 2-hr SBA treatment. 
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Chapter 5 Autophagy induction during SBA treatment and autophagy 
inhibition during SAA treatment. 
5.1. Introduction 
5.1.1. Autophagy 
Autophagy is a highly conserved stress-response mechanism from yeast to 
mammalian cells for the removal of damaged proteins or organelles, and the 
turnover of intracellular components, e.g., essential amino acids. For the induction 
of autophagy, extracellular stress (nutrient deprivation or hypoxia) and intracellular 
stress (accumulation of damaged organelles or aggregation of damaged proteins) are 
involved. Autophagy not only acts as an adaptive response to nutrient starvation, it 
also provides a cell death mechanism to radiotherapy and chemotherapy without the 
participation of caspases (Petitot et al., 2002). In the conventional therapeutic drug 
development, apoptosis, a type I programmed cell death which involves the 
participation of caspases, is a common mechanism in combating cancer cells; 
however, resistance to apoptosis in many cancer cells (Ogier-Denis & Codogno, 
2003) is an obstacle to those apoptotic drugs. Therefore, autophagy, a type II 
programmed cell death, is considered as a backup mechanism when apoptosis is 
suppressed (Lefrance et al , 2007) 
During the development of autophagy, double membranous autophagic 
vacuoles containing degraded Golgi apparatus, polyribosomes, ER and damaged 
proteins are observed in the cytoplasm. The autophagic vacuoles then fuse with 
lysosomes in which the luminal pH is acidic for degradation (Lefranc et al., 2007). 
However, autophagic vacuole-lysosome fusion is impaired when the lysosomal 
proton permeability is increased and the lysosomal hydrolase activity is deteriorated 
(Luzio et al., 2007; Wan et al., 2001). Therefore, lysosomal proton permeability has 
a predominant role in the occurrence of autophagy (Settembre et al., 2008). 
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5.1.2. PI3K/AKT pathway and auotphagy 
At the molecular level, PI3K/ AKT pathway is one of the regulatory pathways 
involved in the formation of autophagy. Phosphatidylinsoitol 3-kinase (PI3K), 
negatively suppressed by specific inhibitors, e.g., wortmannin, and LY294002 
(Petiot et al , 2000), phosphorylates the 3’-hydroxyl group on the inositol ring of the 
phosphoinositides to produce phosphatidylino-sitol-3,4,5-trisphosphate (PIP3) 
(Toker and Cantley, 1997). PIP3 binds and recruits AKT to the cell membrane where 
AKT undergoes conformational change for subsequent phosphorylation (Borgatti et 
al , 2003). AKT, referred to as PKB or Rac, is a serine/threonine kinase which is 
positively or negatively regulated by PI3K or phosphatase and tensin homology 
(PTEN), respectively. Following stimulation with insulin, growth or survival factors, 
AKT is recruited and activated after phosphorylation by phosphoinositide-dependent 
kinase (PDK) 1 and PDK 2 at amino acid residues, Thr308 and Ser473, respectively 
at the plasma membrane (Convey et al , 2007; Marte and Downward, 1997). Once 
phosphorylated, AKT migrates to the nucleus for subsequent cellular actions such as 
survival, proliferation, differentiation and autophagy (Borgatti et al., 2003). Since 
PI3K/AKT pathway suppresses autophagy, effective inhibition on this pathway is a 
common strategy to sensitize the cancer cells to chemotherapy and radiotherapy via 
autophagy induction (Fujiwara et al , 2007). Recently, LY294002 (inhibitor of PDK), 
phosphatidyl inositol analogues (inhibitor of AKT) and rapamycin (inhibitor of AKT 
downstream protein, mTOR) have been extensively investigated in the hope of 
overcoming the PDK/AKT conferred chemotherapy-resistance of cancer cells 
(Fugiwara et al., 2007; Lefranc et al., 2007). Therefore, a study on the participation 
of PI3K/AKT pathway might provide a better understanding on the autophagy 
induced by SAA and/or SBA. 
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5.2. Materials and methods 
5.2.1. Ultrastructural changes of HT29 cells by transmission electron 
microscopy 
For ultrastructural observation by transmission electron microscopy, both SAA-
or SBA-treated HT29 cells were fixed in 2 % glutaraldehyde in 0.08 M cacodylic 
acid, pH 7.4 for 2 hr, washed in 0.08% cacodylic buffer for 30 min, and post-fixed 
with 0.1% 0s04 for 10 min. After several washes in distilled water, the preparations 
were dehydrated through a graded series of ethanol (50%, 70%, 80%, 95% and 
100%), embedded in Epon, sectioned and stained with lead citrate and uranylacetate 
for transmission electron microscopic analysis (Hitachi H600 Electron microscope, 
Japan). 
5.2.2. Detection of acidic vesicles by flow cytometry 
For detecting the acidic vesicles, acridine orange (AO, Sigma), a cell permeable 
metachromic and lysosomotropic dye, fluorescences green in the cytoplasm, dim red 
in the nucleus, and bright red in the acidic vesicle. Thirty minutes before terminating 
the experiment, 2 |ig/ml AO was loaded into the cultured cells during the 2 hr SAA 
and SBA treatment. After treatment with SBA or SAA for two hours, cells were 
trypsinized and the fluorescence of AO uptaken by the cells was determined using a 
flow cytometer (Beckman Coulter) with an argon laser. The bright red fluorescence 
(>650 nm) increased with the formation of the acidic vesicles and the signal 
decreased when lysosomes were ruptured (Komata et al., 2004; Paglin et al., 2004). 
5.2.3. Analysis of lysosomal integrity by confocal laser scanning microscopy 
(LysoTracker-Red DND-99) 
Before the SAA/SBA treatments, cells were loaded with 50 nM of LysoTracker 
Red DND-99 (Molecular Probes) for 30 min, washed thoroughly with PBS to 
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remove the excess dye, and further cultured in the fresh medium before the real-time 
changing of lysosomal integrity of the cells was measured using a confocal laser 
scanning microscope (Olympus). Punctuated bright red fluorescent pattern (590nm) 
was observed in the healthy cells, but the fluorescence became dimmer after the 
drug treatment. 
5.2.4. Immunofluorescence microscopy of p-AKT "^'^ ®^ and p-AKT '^''^ ^^ 
The cellular localization of phosphorylated AKT was identified by 
immunofluorescence microscopy. After appropriate treatment, cells were 
immediately fixed in 3.7% paraformaldehyde for 10 min at RT, washed with PBS 
twice, and permeablized with 0.2% triton X-100 in PBS for 10 min at RT. Before 
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incubating cells with antibodies against phosphospecific AKT (Cell Signaling 
Tech., Inc., Danvers, MA, USA) or phosphospecific AKT^®'^ '^ ^ (Cell Signaling Tech.) 
in 4°C, non-specific binding of the cells was blocked by 2% bovine serum albumin 
(BSA) for 30 min. Bound antibodies were subsequently detected by incubation with 
secondary antibody conjugated with either Alexa-488 or Alexa-594 (Invitrogen) for 
1 hr in 2% BSA. The cell nuclei were counterstained with 1 ng/ml DAPI, mounted 
with anti-fade solution (Molecular Probes), and analyzed by confocal laser scanning 
microscopy (Olympus). 
5.2.5. Quantification of p-AktS®*^?〗 expression using an ELIZA kit 
According to the manufacturer's protocol, cells were rinsed with cold PBS 
twice, and immediately lysed with lysing buffer after appropriate treatments. Before 
transferring to the p-AKT "^""^ ^^  antibody-coated ELIZA plate (Cell Signaling Tech.), 
lysates were diluted with the "Sample Diluent" in 1:1 ratio (v/v). Diluted samples 
were incubated in the antibody pre-absorbed plate overnight at 4 then washed 
four times with washing buffer between each of following steps: incubating with 
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detection antibody for 1 hr at 37�C; addition of HRP-linked secondary antibody for 
30 min at 37 °C; colour development by reacting with TMB substrate for 10 min at 
37 ®C before termination of the reaction with the "Stop Buffer，，. Absorbance was 
read at 450 run using a 96-well microplate reader (Model 680，Bio-Rad Lab., Inc., 
Japan). The amount of p-AKT^ ®*""*^ ^ of each sample was normalized with same 




5.3.1. Ultrastructure of HT29 cells 
The ultrastructural analysis provides cellular and subcellular (e.g., organelles) 
morphology in detail by a powerful transmission electron microscope (TEM) that 
cannot be observed by a conventional light microscope. An intact oval nucleus (Fig. 
5.1 a), oblong mitochondria with well-defined inner and outer membrane, matrix, 
intermembranous space, and shelf-like cristae were observed in normal HT29 cells 
(Fig 5.1 b). When cells were challenged with 10 mM SAA for 2 hr, vacuoles 
(Fig. 5.1 c), and distorted mitochondria with increased matrix space and destruction 
of cristae were observed (Fig. 5.1 d). Although distorted mitochondria were not 
found in 10 mM SBA-treated cells, some black condensed vacuoles containing 
damaged proteins and organelles bound by single membrane, indicative of autophagy, 
were observed in the cytoplasm. After a 2-hr treatment with 10 mM SAA or 10 mM 
SBA, numerous autophagic vacuoles were only observed in the cytoplasm of 
SBA-treated cells (Figs. 5.1 e & f), but not in the untreated controls or SAA-treated 
samples (Figs. 5.1 a & c). 
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Figure 5.1. Transmission electronic microscopic examinations of HT29 cells. 
Oblong mitochondria (b) of the control cell (a) were shown, while 
distort mitochondria with increased matrix space and destructed cristae 
(d) were found in SAA-treated cell (c) in which vacuoles (black arrow) 
were also observed. Autophagic vacuoles (e, red arrowhead) were found 
in SBA-treated cell (f). (a), (c) & (e) were captured at magnification of 
1200X; while (b), (d) & (f) were at 6000X. 
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5.3.2. Acidic vesicle formation 
In concomitant with the TEM results, SBA-treated cells showed increased 
acidic vesicle formation with higher fluorescence intensity than control cells 
(Fig. 5.2 d, 32.19% vs 25.45%, respectively). On the other hand, SAA-treated cells 
showed a reduction in the fluorescence intensity (Fig. 5.2 d, 19.21%), probably 
because of the rupture of lysosomes (Fig. 5.2 b) which was further confirmed by a 
decrease of intact lysosomes analysed by lysosome-specific dye, LysoTracker 
DND-99 in SAA-treated cells (Figs. 5.4 a & c). In order to have a better 
understanding of the autophagy induction, ROS scavenger (NAC) and PI3K-specific 
inhibitor (LY294002) were used in SBA-treated cells (Figs. 5.3 a - f). Since PI3K, a 
well documented kinase, is responsible for the activation of AKT and suppression of 
autophagy formation, a reduction of PI3K by its inhibitor LY294002 may result in 
autophagy formation (Fujiwara et al., 2007; Lefranc et al , 2007; Takeuchi et al., 
2005). There were significant difference in the acidic vesicle ratio between untreated 
control, NAC and LY294002 pre-treated samples in which the ratio were 1.7，1 and 
2.5, respectively (Fig. 5.3 g, p < 0.05). These results demonstrate that LY294002 
increased, while NAC decreased acidic vesicle formation in SBA-treated cells, and 
that NAC-inhibitable oxidative stress was the primary inducing factor of autophagy 
while inhibition of PI3K only resulted in an augment of autophagy induction 
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Figure 5.2. Flow cytomatric analysis of acidic vesicle formation. Cells were 
exposed to supravital stain acridine orange after 2 hr treatment with 
SAA or SBA. The shown histograms are the representatives of control 
(a), 10 mM SAA-treated (b), or 10 mM SBA-treated samples (c). 
Change in the intensity of acridine orange in control, 10 mM SAA treated, or 10 mM SBA-treated samples and the mean 土 SD of iplicate individual experiments were shown i  (d). 
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Figure 5.3. Quantification of acidic vesicle with acridine orange using flow 
cytometric analysis. The shown histograms are the representatives of 
the samples which were left untouched (a & b)，or pre-treated with 10 
mM NAC (c & d) or 200 ^M LY294002 (e & f) before challenging 
with 10 mM SBA for 2 hr. The acidic vesicle formation in control (a, c 
& e) and the SBA-treated samples (b, d & f) were then measured by 
flow cytometry. Comparison of the acidic vesicle formation ratio 
between control and treated sample under same pre-treatment condition 
was shown in (g). 
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5.3.3. Integrity of lysosomes 
An intact lysosome is essential for the formation of an autophagy, and its 
integrity as reflected by lysosomal permeability and intralysosomal pH can be 
assessed by LysoTracker DND-99, a fluorescence dye preferentially accumulated in 
the acidic compartments (Wan et al., 2001). The kinetic change of fluorescence 
intensity was monitored for 2 hr; and the graphs show that both control and 
SBA-treated samples had similar fluorescence reduction rates, while SAA had 
higher rate (Fig. 5.4 a). The fluorescence intensity of both control and SBA-treated 
samples were nearly the same at 30 min after the treatment, while SAA-treated 
sample was the lowest (Figs. 5.4 b - d), indicating the lysosomes were intact in the 
untreated control and the SBA-treated samples, but became ruptured in the 
SAA-treated sample. A comparative study was taken at 30 min but longer live 
imaging was hindered by photobleaching and a gradual reduction of fluorescence 
even in the control samples. 
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Figure 5.4. Analyses of the integrity of lysosomes by confocal laser scanning 
microscopy. The kinetic changes of the fluorescence intensity were 
measured for every 5 min and total time taken was 2 hr. (a). The shown 
images of control (b), SAA-treated (c), and SBA-treated (d) samples 
were captured 30 min after treatment when the difference of the 
fluorescence intensity was largest among control, SAA or SBA-treated 
samples (b - d). 
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5.3.4. Phosphorylation of AKT 
The serine/theronine kinase AKT regulates diverse biological processes, 
including survival, proliferation and glycogen metabolism. Brazil and Hemmings 
(2001) suggested that phosphorylation at both Thr308 and Ser473 are required for 
full activation of AKT, and the activated AKT is then migrated from the plasma 
membrane to the nucleus for subsequent actions (Borgatti et a l , 2003; Brazil and 
Hemmings, 2001). Figs. 5.5 a - f show the amount of p-AKT™08 only increased 
slightly in SAA-treated cells (Figs. 5.5 b & e), but dramatically in SBA-treated cells 
(Figs. 5.5 c & f). In consistent with the expression level of p-AKT'^ '^'^ ®^ the 
p-AKTSer473 level in SBA-treated cells was also the highest among three groups (Figs. 
5.5 g - 1). Quantification of p-AKT^ ®^ "^ ^^  of these findings was carried out using a 
commercial ELISA kit, and the results show a 4-fold expression of p-AKT^ ®^ "^ ^^  in 
SBA-treated sample when compared with the untreated control or SAA-treated 
samples (Fig. 5.6). Apart from their up-regulation, both p-AKT™®^and p-AKT^®'^ '^ ^ 
were translocalized into the nuclei of the SBA-treated cells (Figs 5.5 c, f, i, 1), 
implicating that AKT was activated in SBA-treated samples but not in control or 
SAA-treated samples. The induction of p-AKT^ ®'"'^ ^^  was greatly reduced by two 
inhibitors (i.e., 10 mM NAC or 200 i^M LY294002) in 10 mM SBA-treated cells， 
implicating that both oxidative stress and PDK activity were involved in AKT 
phosphorylation (Fig. 5.7). 
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Figure 5.5. Immunofluorescence microscopic analyses of p-AKTTh测 and 
p-AKTSer473 distribution in HT29 cells. Cells were stained with 
p-AKTThr308 (a - f) or p-AKTSer473 (g . 1) antibody and then 
counterstained with DAPI. Low expression level of both p-AKT^ *^ "^ ®^^  
and p-AKTSer473 were found in control (a, d, g & j) and 10 mM 
SAA-treated (b，e, h & k) samples, while higher nuclear expression of 
both phosphorylated forms of AKT were observed in SBA-treated 
sample (c, f, i, 1). All the confocal images were captured at 
magnification of SOX. 
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Figure 5.6. Quantification of p-AKT^®'''^ ^^  expression in ascorbates treated samples 
after 2 hr-treatment by ELISA assay. The amount of p-AKT^®'"^ ^^  is 
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Figure 5.7. The changes in the expression and distribution of p-AKT^ ® '^^ ^^  in SBA 
treated samples by NAC or LY294002. HT29 cells were left untouched 
(a & b)，pre-treated with lOmM NAC (c & d) or 200 ^M LY294002 
(e & f) before challenging with lOmM SBA for 2 hr. The nuclear 
localization of p-AKT^ *^^ "^ ^^  was characterized by overlapping with 
DAPI (b, d & f). All confocal images were captured at magnification of 
80X. 
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5.3.5. Kinetic analysis of p-AKT^ ®'^ ''^ ^ expression 
Confocal images in figs. 5.6 a - d show that oxidative stress induced by SBA 
triggered AKT phosphorylation, therefore I speculated that AKT phosphorylation 
might be lowered after removal of SBA. To test this hypothesis, cells were further 
cultured in SBA-free medium for another 2 to 4 hr, and then fixed or harvested for 
immunofluorescence microscopy or ELISA analysis, respectively. Interestingly, 
p-AKT was significantly enhanced from 0.016 to 0.022 units (arbitrary units, p < 
0.001) 2 hr after removal of SBA, and then dropped to 0.013 units for the next 2 hr 
(Fig. 5.8 a, control is 0.005 units, p < 0.001). The ELISA results were consistent to 
another separated immunofluorescence experiment in which the signal of nuclear 
p-AKTSer473 reached to the peak level at 2 hr after the treatment, and then declined to 
the basal level (Figs. 5.7 b - g). However, these results are contradictory to the 
hypothesis, further investigation is thus necessary to determine the role(s) of p-AKT 
before and after the treatment. 
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Figure 5.8. Kinetic analyses of p-AKT^''^''^ in HT29 cells after lOmM SBA 
treatment. After 2 hr-SBA treatment, cells were harvested at 0，2 and 4 
hr and then subjected to quantification by ELISA (a) or observation by 
immunofluorescence microscopy (b - g). The amount of p-AKT^ ®*^ "^ ^^  is 
expressed per |ag protein and the values are the mean 士SD of triplicate 
samples in the ELISA assay. The nuclear localization of p-AKT^ ®*^ "^ ^^  
was characterized by overlapping with DAPI (e - g). All confocal 
images were captured at magnification of SOX. 
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5.3.6. Relationship between cell cycle arrest and autophagy induction 
The cell cycle arrest and autophagy are regulated by different subsets of 
proteins, Mukohara et al. (2005) suggested that a combination of lapatinib with 
LY294002 or rapamycin caused greater growth inhibition than individual drug in the 
cells. Therefore, both LY294002 and SBA were used together in treating cells to see 
whether this combination had a greater synergistic effect in growth inhibition than 
SBA alone. Flow cytometic analysis of the DNA pattern between SBA-treated and 
SBA+LY294002-treated cells showed that their DNA patterns were similar at 20h 
and 28h of the cell cycle, and the addition of LY294002 could not further delay the 
cell cycle arrest even AKT was inhibited from phosphorylation (Figs. 5.9 a & b). 
Taken these results together, the growth inhibition can neither be reduced nor 
enhanced by a suppression of AKT phosphorylation, and the relationship between 
cell cycle arrest and autophagy was weak. 
I SBA SBA 






Figure 5.9. Cell cycle analyses of HT29 cells after SBA treatment in the presence 
of PI3K inhibitor. After 2 hr 10 mM SBA treatment in the presence or 
absence of200^M LY294002, cells were harvested at 20h (a) or 28h (b) 
of the cell cycle and subjected to flow cytometry analysis for the DNA 
pattern analyses. The data shown are representative of three 
independent experiments with similar results, and 10,000 cells were 
analyzed for each experiment. 
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5.4. Discussion 
In response to oxidative stress, autophagy, a self-digestion process, is 
developed to degrade and remove damaged organelles and proteins, and lead to cell 
death when the stress is sustained for a long time (Lefranc et al., 2007). In the current 
study, SBA triggered autophagy in HT29 cells as demonstrated by the formation of 
autophagic vacuoles and the increase of acidic vesicles (Figs. 5.1 & 5.2). However, 
the autophagy is abolished by an addition of oxidant scavenger NAC, indicating an 
oxidative response of the cells to oxidative stress by SBA (Figs. 5.3 c & d)’ or the 
loss of lysosomal integrity as shown in SAA-treated cells (Figs. 5.2 b & 5.4 c) 
(Settembre et al., 2008). Similar intact lysosomes were found in both untreated 
control and SBA-treated cells (Fig. 5.4 a, b & d) even though the SBA-cells are 
under drastic oxidative stress. 
Interestingly, activation of AKT, a well-documented inhibitor of autophagy, was 
demonstrated by the double phosphorylation of the AKT at Thr308 and Ser473, and 
the nuclear translocation after SBA treatment (Figs. 5.5 c，f，i & 1)，but its expression 
is contradictory to the appearance of autophagy as shown by both electron 
microscopy and flow cytometry. The imminent functions of the p-AKT in SBA 
treatment are not clear, but it is unlikely to act as the cell growth inhibitor as 
suppression of PI3K inhibitor LY294002 could not resume the cell cycle progression 
(Figs. 5.9 a & b). Based on the results in figs. 5.7 a - f, AKT expression may be a 
response to (1) oxidative stress, (2) activation of PI3K, or (3) a 
"compensatory/feedback" response of the cells to autophagy. The 
"compensatory/feedback" hypothesis was supported by an increasing acidic 
vesicles/autophagy in the cells with co-treatment of SBA and LY294002 (Figs. 5.3 e 
& f) which also agree with the findings of Takeuchi (2005) that blockage of PI3K 
further sensitizes cells to autophagy induction. If the SBA treatment is sustained for a 
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longer period of time, absence of AKT phosphorylation will be resulted in autophagy 
with inactivated AKT (Aoki et al, 2007; Kuo et al , 2006). 
AKT not only inhibits autophagy, it also promotes the cell survival and the 
proliferation via phosphorylating proteins (FOXO, GSK3, p27, p21,.. etc.) which are 
responsible for apoptosis or cell cycle arrest induction (Manning & Cantley, 2007). 
The continuous induction of p-AKT^"''^ '^ ^ after 2 hr SBA treatment (Figs. 5.8 a - g) 
may prepare for the re-entry into the cell cycle after transient cell cycle arrest. 
Further intensive investigation of p-AKT activation is needed to elucidate its role 
during and after SBA treatment. 
In contrast to SBA, SAA did not induce autophagy as neither autophagic 
vacuole nor acidic vesicle was observed (Figs 5.1 c & d, 5.2 b) although SAA is a 
well-known oxidant at high concentrations. The failure in the induction of 
autophagy may be a consequence of the loss of lysosomal integrity by large amount 
of H2O2 (from SAA) which leads to oxidation of lysosomal contents and 
permeabilization of the lysosomal membrane (Kurz et al , 2007). It is, however, 
unclear if the inactivation of AKT may also play any role in the maintenance of 
lysosomal integrity. 
In conclusion, autophagy was induced by the massive oxidative stress in SBA 
treatment with the dramatic increase of phosphorylated AKT. On the other hand, 
SAA failed to induce autophagy as lysosomes started to rupture as early as 30 min 
after the treatment. No specific relationship was shown between autophagy and cell 
cycle arrest because supplementation with PI3K blocker did not alter the cell cycle 
arrest after SBA treatment. 
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Chapter 6 General discussion 
The increasing risks of colorectal cancer and the destructive side effects of 
conventional synthetic drugs, e.g., 5-FU, urge the development of alternative 
medicine from natural products with low side effects. Decades of research on 
flavonoids, triterpenes, and vitamins from botanical sources show that these 
compounds are effective in killing colon cancer cells via the induction of oxidative 
stress. Among the vitamins, vitamin D has been demonstrated in both in vitro and in 
vivo experiments for its potential anti-colon cancer activities through a modification 
of cell cycle regulatory proteins, e.g., cyclin D, p21 and p27, and/or an up-regulation 
of pro-apoptotic proteins, e.g., BAK and BAX (Lamprecht & Lipkin, 2003). 
Although not as extensively studied in colon cancers like vitamin D, vitamin C (acid 
form of sodium ascorbate, SAA) has demonstrated its destructive roles to other 
cancers, such as lymphoma, melanoma and prostate cancers (Chen et al., 2005; 
Kang et al., 2005; Maramag et al., 1997). At pharmacological doses (0.3 - 20 mM), 
SAA induced cancer cell arrest and apoptosis (Thomas et al., 2005) through 
production of H2O2 (Chen et al” 2005) and reduction of iron uptake (Kang et al., 
2005). On the other hand, both previous findings (Sakagami et al., 1997) and the 
present study show that SBA also possessed anti-tumor properties via ROS 
production that could not be inhibited by catalase(Fig. 3.1 b); implicating that SAA 
and SBA may trigger different signaling pathways for oxidant production and 
subsequent cell death. To compare the modes of anti-tumor actions of both 
ascorbates, colon cancer HT29 cells were subjected to a 2-hr short-term exposure, 
and the results show that SAA induced a transient cell cycle arrest (< 8 hr, Fig. 4.6) 
and destabilized lysosomal integrity (Figs. 5.2 b，5.4 a & c). SBA delayed the cell 
cycle progression for a longer period (delay 8 hr) (Fig. 4.6) as well as activated AKT 
and induced autophagy (Figs 5.1 e & f，5.2 c). The different signaling pathways 
triggered by SAA and SBA are proposed in the following diagram. 
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Reactive oxygen species (ROS), a group of oxygen radicals containing one or 
more uncoupled electrons in their highest atomic or molecular orbitals, is not only a 
by-product of metabolism, but also a secondary messenger for various cellular signal 
transductions (Valko et al , 2007). It can enhance proliferation during normal 
metabolism, or induce transient to permanent cell cycle arrests, apoptosis and 
ultimately leading to cell death, depending on its amount and exposure duration 
(Boonstra & Post，2004). As shown in the schematic diagram, ROS is the primary 
inducing factor for signaling cascade in both SAA- and SBA-treated cells. When the 
formation of ROS was inhibited by catalase or NAC, the cascades were abolished 
(Figs. 4.7 b & f，5.3 b & d). 
Treatment of HT29 cells with either SAA or SBA induced production of large 
amount of ROS in a time dependent manner (3.5% and 25%, respectively) (Fig. 3.1a). 
To defend the cells against the oxidative damage, cell progression was transiently 
interrupted in different degrees depending on the amount of ROS; and time is given 
to the cells to repair DNA and/or trigger adaptive response before the cells re-enter 
the cell cycle (Davies, 2000). At 20h of the cell cycle, 72% and 48% cells entered the 
S phase for 5mM and lOmM SAA treatment, respectively, while 65% and 26% cells 
entered the S phase for 5mM and lOmM SBA treatment, respectively (Fig. 4.7 b). 
These data not only point out the degree of transient cell cycle arrest was in a 
dose-dependent manner, they also show that SBA had a stronger cell cycle inhibitory 
property than SAA. Moreover, lOmM SBA treated cells showed a lag of 8 hr in each 
time point of the experiment (Figs. 4.7 a, b & c). As SAA and SBA only inhibited 
cells at various extents transiently, cells were able to proliferate after DNA was 
repaired. The trypan blue exclusion assay confirmed with this hypothesis that all 
treated samples were able to proliferate and the cell numbers of all samples were 
doubled at 36h of the cell cycle (Fig. 2.2). The current study agrees with other studies 
« 
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that sublethal doses of H2O2and vitamin C induced transient Gl, S and G2 multiple 
arrests in mouse fibroblasts and HeLa cells (Bamouin et al., 2002; Thomas et al., 
2005). 
For the anti-oxidative stress, oxidative enzyme inhibitors and anti-oxidants, e.g., 
DPI, L-NAME, rotenone, and NAC, reduced the production of intracellular ROS by 
20%, 35%, 50% and 85%, respectively (Fig. 3.1 b). Interestingly, DPI, L-NAME and 
rotenone failed to fully restore the cell cycle progression as NAC, which is most 
probably due to the amount of intracellular ROS induced by SBA treatment had 
already exceeded the “threshold level" Therefore, cell cycle can progress normally 
only when the ROS level is kept below the "threshold level". 
Progression through the cell cycle from phase to phase requires precise 
coordination of a number of regulators (cyclins, Cdks, and Ckis), otherwise, growth 
arrest will be resulted. Treatment with H2O2 in p53-mutant fibroblasts increased 
cyclin-dependent kinase inhibitor (e.g., p21 protein), and decreased cyclin D and 
cyclin D/Cdk4 activity, that ultimately resulted in a transient Gl arrest (Bamouin et 
al , 2002). Similarly, treatment with sulforaphane in HT29 cells also repressed cyclin 
D and induced p21 in a Gl arrest (Shen et al , 2006). In the current cell cycle 
analysis, temporary reduction of cyclin D, PCNA and up-regulation of p21 (Figs. 
4.14 a, b & c) associated with a transient Gl arrest were observed in both SAA and 
SBA-treated cells (Figs. 4.6 g & k，4.7 a & b). 
Apart from the alteration of protein expression, inhibitory quaternary complex 
formation among p21 protein, PCNA, Cyclin D and Cdk4/6 is commonly found in 
Gl arrested cells (Ando et al., 2001). The results of immunoprecipitation had further 
demonstrated that the binding of p21 to the cyclin D resulted in a cell cycle arrest of 
both SAA- and SBA-treated cells in the Gl phase (Fig. 4.16). The stronger ROS 
production and p21 up-regulation are likely the reason for a sustained delay of the 
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Gl arrest in the SBA-treated cells (Fig. 4.17). 
Being a critical executor in the cell cycle inhibition, p21 is able to bind to 
different cyclin/Cdk complexes (cyclin D/Cdk2,4; cyclin A, E/Cdk 2; cyclin B/cdc 2) 
and results in multiphase arrests (Thomas et al , 2005). Without the participation of 
p21, the p21-deficient cells after treatment with DNA-damage agents such as 
irradiation and anti-cancer drugs failed to arrest but died by apoptosis (Bunz et al , 
1998; Chan et al , 2000). Because of the binding multiplicity of p21 to cyclin/Cdk 
complexes, SBA treatment had been performed in different cell cycle phases, and 
results of the experiments had further demonstrated cell cycle inhibition could be 
induced in all phases of the cell cycle (Figs 4.11 & 4.13). 
Autophagy is frequently found when cell cycle arrest is observed (Arai et al., 
2001). It is a degradative process which is regulated by PI3K/AKT pathway with the 
participation of the lysosomes for the removal of long-lived damaged proteins, e.g., 
oxidized proteins and defective organelles during starvation (Ogier-Denis & 
Codogno, 2003). It is also considered as the type II programmed cell death (Codogno 
& Meijer，2005). Colon cancer cells including SW480, CaCo2, HCT116 and HT29 
cells have been reported as good models for the demonstration of autophagy (Comes 
et al., 2007), and other cells such as breast cancer MCF-7 cells (Bursch et al., 2000) 
and retinal ganglion cells (Kim et al , 2008) also manifest autophagy after tamoxifen 
treatment and optic nerve transaction, respectively. Treatment of the HT29 cells with 
SBA induced acute oxidative stress (Fig. 3.1 a) and autophagy which is characterized 
by autophagic vacuole formation (Figs 5.1 e & f). Since ROS has been proposed as 
the essential activator of autophagy (Scherz-Shouval et al., 2007), our results agreed 
with this finding that acidic vesicles formation (characterized feature of autophagy) 
was reduced to the level of the untreated control (Fig. 5.3 d) when oxidative stress 
was removed by antioxidant NAC (Fig. 3.1 b). No autophagy was observed in the 
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SAA-treated cells, which is most likely due to a lack of the functional participation 
of the intact lysosomes (Figs. 5.2 b & 5.4 c) (Settembre et al , 2008). 
Apart from the oxidative effect, the underlying molecular mechanisms involving 
PI3K and AKT were investigated with a specific PDK inhibitor, LY294002. In 
contrast to the common belief about phosphorylated AKT being a key inhibitor to 
autophagy, full activation of AKT was observed in autophagic HT29 cells after SBA 
treatment (Figs. 5.5 f & 1). The role of AKT remains unclear with the current results, 
its activation may be a "compensatory/feedback" mechanism to defend against 
autophagy. The hypothesis is based on the increase of acidic vesicle formation when 
AKT was inhibited from phosphorylation indirectly by co-administration of 
LY294002 and SBA (Figs. 5.3 e. f & g); implicating that the degree of autophagy 
may increase without AKT participation in SBA treatment. 
In this current study, the relationship between autophagy and cell cycle 
progression was also studied. It has been reported that blocking of PDK can suppress 
the cell cycle arrest in the G1 phase (Ami et al., 2001). However, co-incubation with 
SBA and LY294002 failed to interfere with the delay period of the cell cycle (Figs. 
5.9 a & b), indicating no direct relationship between SBA-mediated autophagy and 
cell cycle arrest. 
In conclusion, SAA and SBA were shown to induce oxidative stress in the HT29 
cells within 2-hr short term treatment via a catalase- and NAC-inhibitable manner, 
respectively. SAA showed a higher cytotoxic effect than SBA via transient cell cycle 
arrest and lysosomal rupture, but it is not suitable for in vivo application because it 
killed more normal fibroblasts than colon cancer HT29 cells. On the other hand, SBA 
triggered transient cell cycle arrest for a longer period and induced autophagy 
without damaging lysosomes and killing normal fibroblasts. During the transient G1 
cell cycle arrest, temporary up-regulation of p21, and down-regulation of cyclin D 
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and PCNA were observed. Results indicated that SBA not only arrested the cells at 
the G1 phase, but is also capable to inhibit the cells from progression at the S and G2 
phases. Besides, SBA also triggered autophagy, indicative of the type II cell death, 
with the dramatic activation of AKT in which is opposite to the common belief. 
Therefore, further investigation will be required to find out the activation of AKT 
whether is a "compensatory/feedback" mechanism to an acute oxidative stress or is a 
new pathway for autophagy induction. Moreover, the anti-tumor activity of SBA 
should be examined in an in vivo study before it can be considered as a possible 
chemotherapeutic agent for treating colon cancer. 
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